COHEN VETERANS BIOSCIENCE INC: Form 990, tax year 2021

View the entire original 990 at ProPublica ↗

Organization: COHEN VETERANS BIOSCIENCE INC (EIN 47-1981973)
Tax period: 2021-07-01 to 2022-06-30
Filed: 2023-04-28
IRS object ID: 202341189349301159
Schema version: 2021v4.2
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule C
Schedule D
Schedule F
Schedule G
Schedule I
Schedule J
Schedule O
Schedule R

Return header ReturnHeader

Field	Value	IRS element (for citing)
Return	2023-04-28T14:41:32-05:00	ReturnTs
Tax Period End	2022-06-30	TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Field	Value	IRS element (for citing)
Preparer Firm EIN	431985162	PreparerFirmEIN

Preparer Firm Name PreparerFirmName

Field	Value	IRS element (for citing)
Business Name Line1	SMITH SULLIVAN & BROWN PC	BusinessNameLine1Txt

Preparer US Address PreparerUSAddress

Field	Value	IRS element (for citing)
Address Line1	80 FLANDERS ROAD - SUITE 200	AddressLine1Txt
City	WESTBOROUGH	CityNm
State Abbreviation	MA	StateAbbreviationCd
ZIP	01581	ZIPCd

Field	Value	IRS element (for citing)
Return Type	990	ReturnTypeCd
Tax Period Begin	2021-07-01	TaxPeriodBeginDt

Filer Filer

Field	Value	IRS element (for citing)
EIN	471981973	EIN

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	COHEN VETERANS BIOSCIENCE INC	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Business Name Control	COHE	BusinessNameControlTxt
Phone	6469704325	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	535 8TH AVENUE 12TH FLOOR	AddressLine1Txt
City	NEW YORK	CityNm
State Abbreviation	NY	StateAbbreviationCd
ZIP	10018	ZIPCd

Business Officer BusinessOfficerGrp

Field	Value	IRS element (for citing)
Person	MAGALI HAAS MD PHD	PersonNm
Person Title	CEO & PRESIDENT	PersonTitleTxt
Phone	6469704325	PhoneNum
Signature	2023-04-28	SignatureDt
Discuss With Paid Preparer	Yes (1)	DiscussWithPaidPreparerInd

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

Field	Value	IRS element (for citing)
Person First	MAGALI	PersonFirstNm
Person Last	HAAS MD PHD	PersonLastNm

Field	Value	IRS element (for citing)
SSN	999009999	SSN

Preparer Person PreparerPersonGrp

Field	Value	IRS element (for citing)
Preparer Person	SANDRA M BROWN CPA	PreparerPersonNm
PTIN	P01614103	PTIN
Phone	5088717178	PhoneNum
Preparation	2023-04-28	PreparationDt

Additional Filer Information AdditionalFilerInformation

Trusted Customer TrustedCustomerGrp

Field	Value	IRS element (for citing)
Trusted Customer	3	TrustedCustomerCd
Authentication Assurance Level	AAL1	AuthenticationAssuranceLevelCd
Identity Assurance Level	IAL1	IdentityAssuranceLevelCd

Field	Value	IRS element (for citing)
Tax	2021	TaxYr
Build TS	2023-04-26 12:10:37Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Address Change	Yes (X)	AddressChangeInd
Amended Return	Yes (X)	AmendedReturnInd
Principal Officer	MAGALI HAAS MD PHD	PrincipalOfficerNm

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	535 8TH AVENUE 12TH FLOOR	AddressLine1Txt
City	NEW YORK	CityNm
State Abbreviation	NY	StateAbbreviationCd
ZIP	10018	ZIPCd

Field	Value	IRS element (for citing)
Gross Receipts	$18,082,398	GrossReceiptsAmt
Group Return For Affiliates	0	GroupReturnForAffiliatesInd
Organization501c3	Yes (X)	Organization501c3Ind
Website Address	WWW.COHENVETERANSBIOSCIENCE.ORG	WebsiteAddressTxt
Type Of Organization Corp	Yes (X)	TypeOfOrganizationCorpInd
Formation	2014	FormationYr
Legal Domicile State	MA	LegalDomicileStateCd
Activity Or Mission	BIOMEDICAL RESEARCH AND TECHNOLOGY ORGANIZATION DEDICATED TO ADVANCING BRAIN HEALTH BY FAST-TRACKING PRECISION DIAGNOSTICS AND TAILORED THERAPEUTICS.	ActivityOrMissionDesc
Voting Members Governing Body	5	VotingMembersGoverningBodyCnt
Voting Members Independent	4	VotingMembersIndependentCnt
Total Employee	46	TotalEmployeeCnt
Total Volunteers	0	TotalVolunteersCnt
Total Gross UBI	$0	TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm	$0	NetUnrelatedBusTxblIncmAmt
PY Contributions Grants	$16,160,581	PYContributionsGrantsAmt
CY Contributions Grants	$17,941,055	CYContributionsGrantsAmt
PY Program Service Revenue	$0	PYProgramServiceRevenueAmt
CY Program Service Revenue	$0	CYProgramServiceRevenueAmt
PY Investment Income	$59,585	PYInvestmentIncomeAmt
CY Investment Income	$28,608	CYInvestmentIncomeAmt
PY Other Revenue	$32,104	PYOtherRevenueAmt
CY Other Revenue	$112,735	CYOtherRevenueAmt
PY Total Revenue	$16,252,270	PYTotalRevenueAmt
CY Total Revenue	$18,082,398	CYTotalRevenueAmt
PY Grants And Similar Paid	$235,660	PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid	$501,347	CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members	$0	PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members	$0	CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid	$8,452,791	PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid	$7,547,333	CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns	$50,600	PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns	$36,000	CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense	$641,308	CYTotalFundraisingExpenseAmt
PY Other Expenses	$9,371,369	PYOtherExpensesAmt
CY Other Expenses	$9,439,104	CYOtherExpensesAmt
PY Total Expenses	$18,110,420	PYTotalExpensesAmt
CY Total Expenses	$17,523,784	CYTotalExpensesAmt
PY Revenues Less Expenses	-$1,858,150	PYRevenuesLessExpensesAmt
CY Revenues Less Expenses	$558,614	CYRevenuesLessExpensesAmt
Total Assets BOY	$17,952,584	TotalAssetsBOYAmt
Total Assets EOY	$15,587,351	TotalAssetsEOYAmt
Total Liabilities BOY	$6,826,523	TotalLiabilitiesBOYAmt
Total Liabilities EOY	$3,699,826	TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY	$11,126,061	NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY	$11,887,525	NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part III	Yes (X)	InfoInScheduleOPartIIIInd
Mission	COHEN VETERANS BIOSCIENCE, INC. IS A NON-PROFIT 501(C)(3) BIOMEDICAL RESEARCH AND TECHNOLOGY ORGANIZATION DEDICATED TO ADVANCING BRAIN HEALTH BY FAST-TRACKING PRECISION DIAGNOSTICS AND TAILORED THERAPEUTICS.	MissionDesc
Significant New Program Srvc	0	SignificantNewProgramSrvcInd
Significant Change	0	SignificantChangeInd
Expense	$14,959,934	ExpenseAmt
Grant	$501,347	GrantAmt
Desc	BRAIN HEALTH TOOLS & TECHNOLOGIES:IN ORDER TO FAST-TRACK PRECISION DIAGNOSTICS AND TARGETED THERAPEUTICS AND WELLNESS APPROACHES FOR MAINTENANCE AND RESTORATION OF BRAIN HEALTH, CVB IS LEVERAGING INNOVATION AND TECHNOLOGY TO BUILD TOOLS AND PLATFORMS THAT ENABLE DISCOVERY AND DEVELOPMENT ACROSS BRAIN DISEASES. THESE TOOLS & PLATFORMS ALLOW RESEARCHERS FROM ACADEMIA AND INDUSTRY TO ACCESS AND UTILIZE BEST-IN-CLASS PRACTICES AND ALLOW EFFORTS TO BE SCALED WITH RIGOR AND REPRODUCIBILITY.(SEE SCHEDULE O FOR FULL DETAIL OF OUR PROGRAMS)PLATFORM EFFORTS FOCUS ON CAPACITY THAT ENABLES RELIABLE DISCOVERY OF BIOMARKERS AND BIOLOGICAL PATHWAYS THAT ARE TRANSLATIONALLY RELEVANT FOR THE DEVELOPMENT OF DIAGNOSTICS AND THERAPEUTIC TARGETS FOR DRUG AND OTHER MEDICAL INTERVENTIONS. EACH PLATFORM IS CREATING RESEARCH TOOLS (E.G. ANIMAL MODELS, DATA STANDARDS, COMPUTATIONAL MODELS, REFERENCE DATABASES, ETC.) THAT WILL ACCELERATE/FOSTER THESE DISCOVERIES.WITHIN THIS FRAMEWORK, CVB HAS ESTABLISHED BOTH INTRAMURAL (RESEARCH CONDUCTED BY, OR INCLUDING, CVB STAFF OR CONTRACTORS) AND EXTRAMURAL RESEARCH PROGRAMS (RESEARCH CONDUCTED VIA GRANTS OR IN COLLABORATION WITH EXTERNAL ACADEMIC, INDUSTRY, FOUNDATION AND GOVERNMENT PARTNERS) AND ALSO OPERATES SEVERAL PUBLIC-PRIVATE PARTNERSHIPS. THESE COOPERATIVE ALLIANCES ORGANIZE AND FUND A NETWORK OF PARTNERS WHO EACH CONTRIBUTE COMPLEMENTARY AND SYNERGISTIC DATA, CAPABILITIES, OR EXPERTISE TO SUPPORT A COMMON ROADMAP FOR IDENTIFYING DIAGNOSTIC BIOMARKERS, BUILDING PREDICTIVE BRAIN DISEASE MODELS, DEVELOPING ROBUST STANDARDIZED TRANSLATIONAL TOOLS, AND CATALYZING PHARMACEUTICAL DRUG DEVELOPMENT. THE EMPHASIS IS ON TEAM SCIENCE WITH COHEN VETERANS BIOSCIENCE SERVING AS ITS HUB.OUR PLATFORM PROGRAMS CURRENTLY INCLUDE THE BRAINCOMMONS (CLOUD-BASED DATA & ANALYTICS), EARLYSIGNAL (WEARABLE AND HOME SENSORS FOR MONITORING HEALTH STATUS), RAPID-DX (ESTABLISHING BEST PRACTICES FOR DISCOVERY AND VALIDATION OF BIOMARKERS) AND AMP-IT-UP (FOR PRECLINICAL DISCOVERY AND TRANSLATION).BRAINCOMMONS:WE ARE IN A NEW ERA OF BRAIN RESEARCH, WHERE POWERFUL DATA ACQUISITION TECHNOLOGIES ARE GENERATING MULTIMODAL DATA AT INCREASING SCALES. OUR PRIMARY CHALLENGE TODAY EXTENDS BEYOND DATA GENERATION; RATHER, IT LIES IN DATA UTILIZATION AND KNOWLEDGE EXTRACTION. TO ENABLE DISEASE MODELING EFFORTS, AS WELL AS THE DISCOVERY AND REPLICATION OF BIOMARKERS, THERE IS A CRITICAL NEED FOR A PLATFORM THAT CAN HOUSE MULTI-MODAL DATA TYPES, ACROSS DIAGNOSTIC CATEGORIES, IN CONJUNCTION WITH DATA PIPELINES TO ENSURE REPRODUCIBLE ANALYSIS, AND WITH AN ABILITY TO APPLY STATE-OF-THE ART MACHINE-LEARNING ALGORITHMS. THE BRAINCOMMONS AIMS TO DELIVER ON THIS POTENTIAL, AS THE FIRST BIG-DATA CLOUD-BASED PLATFORM FOR COMPUTATIONAL INNOVATION DISCOVERY IN BRAIN DISEASES THAT SUPPORTS RAW DATA INTEGRATION, INTEROPERABILITY BETWEEN SYSTEMS AND A DATA MODEL THAT OFFERS A COMPATIBLE FORMAT ADHERING TO COMMON STANDARDS WHERE ALL THE DATA, NO MATTER THE SIZE OR TYPE, CAN BE COMBINED FOR RE-USE, FUELING DISCOVERY AND COLLABORATION ACROSS THE MULTIDISCIPLINARY AND MULTI-SECTOR RESEARCH COMMUNITY, AND DRIVING DIAGNOSTIC AND THERAPEUTIC INNOVATION TO REDUCE THE BURDEN OF BRAIN-BASED DISORDERS.IN 2022, THE BRAINCOMMONS WAS LAUNCHED TO OUR FIRST COMMUNITY OF RESEARCH PARTNERS IN PTSD, TBI AND PARKINSON'S.EARLYSIGNAL:WEARABLE AND SENSOR TECHNOLOGIES HOLD PROMISE IN THE ASSESSMENT AND CONTINUOUS MONITORING OF PATIENTS IN ORDER TO BETTER SCREEN AND DIAGNOSE, MONITOR DISEASE PROGRESSION, AND OBSERVE INTERVENTION RESPONSE OR LACK THEREOF. DIGITAL HEALTH MONITORING ALSO ALLOWS US TO STUDY BRAIN HEALTH AND DISEASE IN UNPRECEDENTED WAYS, BY TRACKING VARIABLES SUCH AS SLEEP, PHYSICAL ACTIVITY, STRESS AND COGNITION, WE MAY BE ABLE TO BETTER UNDERSTAND WHAT CHANGES OVER TIME - AND TO DEVELOP EARLIER AND PREVENTIVE DIAGNOSTICS AND TREATMENTS TO MAKE A DIFFERENCE IN PATIENTS' LIVES. MEDICAL-GRADE DATA IS NEEDED FOR FDA APPROVAL OF SUCH PLATFORMS FOR USE IN MEDICAL DECISION MAKING AND DATA INTEGRATION IS NECESSARY FOR CLINICIANS' WORKFLOW. THIS PROGRAM SUPPORTS MULTIPLE PARTNERS TO TEST AND VALIDATE WEARABLES, SENSORS, APPS AND OTHER DIGITAL HEALTH TECHNOLOGIES FOR USE IN MONITORING BRAIN HEALTH. IN 2022, CVB, IN PARTNERSHIP WITH UNIVERSITY OF PENNSYLVANIA, COMPLETED A STUDY TO TEST AND VALIDATE THE PERFORMANCE OF WEARABLE AND SENSOR DEVICES FOR THE ASSESSMENT OF SLEEP COMPARED TO GOLD STANDARD POLY-SOMNOGRAPHY, USING CVB-DESIGNED SECURE AUTOMATED DEIDENTIFIED DATA COLLECTION AND CVB'S STUDY MANAGER TOOL TO SUPPORT CONDUCT OF THE TRIAL. IN 2022, WE COMPLETED THE DEVELOPMENT OF OUR "TRIAL-IN-A-BOX" FULLY AUTOMATED CLINICAL TRIAL SOLUTION FOR THE COLLECTION AND AUTOMATED PROCESSING AND ANALYSIS OF DIGITAL HEALTH DATA IN TRADITIONAL, HYBRID, AND FULLY DECENTRALIZED TRIAL FORMATS. IN THE FULLY DECENTRALIZED SETTING, THIS ALLOWS STUDY SPONSORS TO SEND WEARABLE AND HOME SENSOR TECHNOLOGY STUDY KITS DIRECTLY TO ELIGIBLE STUDY PARTICIPANTS WITHOUT REQUIRING THEM TO VISIT A STUDY CENTER, ENABLING A MORE DIVERSE AND OFTEN LESS-STUDIED POPULATION TO PARTICIPATE. THE PROVIDED DEVICES ARE PAIRED WITH A DOWNLOADABLE STUDY APP ON THE PARTICIPANT'S OWN DEVICE TO COLLECT RELATED SUBJECTIVE OUTCOMES SUCH AS TRADITIONAL SCALES OF DEPRESSION, FUNCTION, AND ACTIVITY AS WELL ECOLOGICAL MOMENTARY ASSESSMENTS.RAPID-DIAGNOSTICS (RAPID-DX):A BIOMARKER IS A CHARACTERISTIC THAT IS OBJECTIVELY MEASURED AND EVALUATED AS AN INDICATOR OF A NORMAL OR PATHOLOGIC BIOLOGICAL PROCESS OR A RESPONSE TO A THERAPEUTIC INTERVENTION. DEVELOPING BIOMARKER-BASED DIAGNOSTICS IS ESSENTIAL TO SHIFTING DIAGNOSIS AND TREATMENT OF PSYCHIATRIC AND NEUROLOGIC CONDITIONS (SUCH AS PTSD AND TBI) FROM A SYNDROMIC OR SYMPTOM-BASED APPROACH TO A BIOLOGICAL, MECHANISTICALLY-BASED ONE THAT TARGETS THE EFFECTS OF TRAUMA AT THEIR MOLECULAR ROOTS. MANY POTENTIAL BRAIN-RELATED BIOMARKERS PUBLISHED IN THE LITERATURE HAVE NOT BEEN INDEPENDENTLY REPLICATED OR ADVANCED THROUGH A QUALIFICATION PROCESS FOR REGULATORY APPROVAL AND USE.RAPID-DX IS A PUBLIC-PRIVATE PARTNERSHIP PROGRAM INCLUDING GOVERNMENT, FOUNDATIONS, AND LEADING ACADEMIC CENTERS ESTABLISHED FOR COLLECTING DATA AND PERFORMING STUDIES NECESSARY TO DISCOVER AND REPLICATE BIOMARKERS AND QUALIFY SUCCESSFUL AND RELEVANT CANDIDATES FOR DEVELOPMENT AS CLINICAL DIAGNOSTICS.THROUGH THIS PROGRAM CVB HAS ESTABLISHED THE CVB BIOREPOSITORY IN PARTNERSHIP WITH INDIANA UNIVERSITY. THE GOAL OF THE BIOREPOSITORY IS TO ESTABLISH A CENTRALIZED RESOURCE FOR TISSUE AND BIOSAMPLE STORAGE FOR ENABLING BIOMARKER DISCOVERY, REPLICATION, AND VALIDATION ACROSS A NUMBER OF BRAIN CONDITIONS, INCLUDING POST-TRAUMATIC STRESS DISORDER ("PTSD"), TRAUMATIC BRAIN INJURY ("TBI"), SUICIDE, DEMENTIA, MAJOR DEPRESSIVE DISORDER AND OTHER MENTAL HEALTH DISORDERS, AMONG OTHERS.THE CVB BRAIN BIOREPOSITORY HOUSES BLOOD AND SALIVA SAMPLES THAT WERE COLLECTED AS PART OF BIOMARKER STUDIES DIRECTLY SPONSORED BY COHEN VETERANS BIOSCIENCE OR THROUGH KEY PARTNERSHIP PROGRAMS. OUR BIOREPOSITORY BANKS A VARIETY OF BIOLOGIC SAMPLES INCLUDING, PLASMA, SERUM, AND SALIVA, AND WILL ENCOURAGE FUTURE COLLABORATIONS WITH RESEARCHERS FROM ACADEMIA, INDUSTRY, GOVERNMENT AND FOUNDATIONS.BRAIN TRAUMA PROGRAMS: POST TRAUMATIC STRESS DISORDER AND TRAUMATIC BRAIN INJURY:THIS CVB PROGRAM WAS FOUNDED IN 2015 TO ESTABLISH A NATIONAL RESEARCH ROADMAP FOR PTSD, TBI AND RELATED CONDITIONS (E.G. SUICIDALITY). BRAIN TRAUMA BLUEPRINT - STATE OF THE SCIENCE SUMMITS:THE BRAIN TRAUMA BLUEPRINT (HTTPS://WWW.BRAINTRAUMABLUEPRINT.ORG/) IS A FRAMEWORK TO ESTABLISH ROADMAPS TO ADVANCE PRECISION DIAGNOSTICS AND THERAPEUTICS FOR SURVIVORS OF BRAIN TRAUMA BY OUTLINING RESEARCH GOALS & PRIORITIES, ESTABLISHING CONSENSUS AROUND FAILURE MODES & KNOWLEDGE GAPS, AND DEVELOPING STRATEGIES TO MOVE THE FIELD FORWARD FOR TRAUMA-RELATED CONDITIONS BY FOSTERING COLLABORATION AND RESOURCE ALLOCATION ACROSS THE BROADER STAKEHOLDER COMMUNITY.THE STATE OF THE SCIENCE SUMMITS ARE THE BASIS FOR BUILDING THE ROADMAPS AND ARE DESIGNED AS RETREATS FOR 100 TO 200 STAKEHOLDERS TO COME TOGETHER TO REALIZE TRUE IMPACT. THE STAKEHOLDERS ENCOMPASS A BROAD SWATH OF THE COMMUNITY FROM ACADEMIC INSTITUTIONS TO GOVERNMENT AGENCIES, FOUNDATIONS SUPPORTING TRANSLATIONAL RESEARCH, INDUSTRY AND INDIVIDUALS WITH LIVED EXPERIENCE.EACH SUMMIT SERVES AS A LAUNCHPAD FOR ONGOING WORKING GROUPS TO DEVELOP EVIDENCE-BASED STRATEGIES AND RECOMMENDATIONS ON HOW TO FILL THOSE GAPS, IDENTIFY NEW GAPS AS OTHERS ARE FILLED, AND DISSEMINATE THESE FINDINGS BACK TO THE COMMUNITY AT LARGE THROUGH WHITE PAPERS AND PROCEEDINGS.	Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

Field	Value	IRS element (for citing)
Desc	THE INAUGURAL STATE OF THE SCIENCE SUMMIT ("SOSS"), HELD IN 2018, FOCUSED ON DIAGNOSIS OF TRAUMA-RELATED BRAIN DISORDERS WITH A MAJOR FOCUS ON POST-TRAUMATIC STRESS DISORDER. THE TRAUMA-RELATED BRAIN DISORDERS RESEARCH COMMUNITY HAS IDENTIFIED A NEED TO ESTABLISH A MECHANISM-BASED TAXONOMY FOR THESE CONDITIONS TO ADVANCE BIOMARKER DISCOVERY AS WELL AS DIAGNOSIS AND THERAPEUTIC DEVELOPMENT. A SHIFT FROM A SYNDROMIC CLASSIFICATION SYSTEM TO A MECHANISTIC ONE NECESSITATES A REVIEW OF THE CURRENT SCIENTIFIC KNOWLEDGE, ADOPTION OF NEW SCIENTIFIC MODELS, AND IDENTIFICATION OF RESEARCH AND KNOWLEDGE GAPS. THE SOSS BROUGHT TOGETHER MULTIDISCIPLINARY STAKEHOLDERS WITH DEEP SCIENTIFIC AND CLINICAL EXPERTISE TO ADDRESS THIS PRESSING NEED.THE THEME OF THE SECOND STATE OF THE SCIENCE SUMMIT, HELD IN 2019 WAS PATHS TO TREATMENT FOR TRAUMATIC BRAIN INJURY(S) WITH A FOCUS ON THE TAXONOMY AND NOSOLOGY OF THE CHRONIC SEQUELAE, CHALLENGES AND OPPORTUNITIES IN CLINICAL PRACTICE AND DEVELOPMENT, AND ETIOLOGY AND MECHANISM OF PERSISTENT SYMPTOMS. AS MEASUREMENT TOOLS ADVANCE, RESEARCH HAS BEEN ABLE TO FOCUS ON DIFFERENT TYPES OF INJURY, BEYOND THE MILD, MODERATE, AND SEVERE CLASSIFICATIONS OF TBI. TO AUGMENT AND SUPPORT THE MANY EFFORTS ACROSS FIELDS AND ORGANIZATIONS OVER THE PAST DECADE, IN 2020 WE WORKED WITH THOUGHT LEADERS ACROSS TBI TO PREPARE A CONSENSUS BLUEPRINT TO DRIVE TRANSLATIONAL SCIENCE FOR TBI. IN 2021, WE PUBLISHED SIX CONSENSUS ARTICLES FROM THE TBI SUMMIT IN THE JOURNAL OF NEUROTRAUMA OUTLINING GAPS AND RECOMMENDATIONS FOR FUTURE RESEARCH.IN 2022, WE HELD THE FIRST BRAIN TRAUMA ACTION SUMMIT, TO PLAN TO EXECUTE THE TBI PRECISION RESEARCH ROADMAP, THROUGH COLLECTIVE PUBLIC AND PRIVATE ACTION.BEST BIOMARKER PTSD STUDY:DESPITE THE EFFICACY OF PSYCHOTHERAPY AS FIRST-LINE TREATMENT FOR PTSD, LARGE INTER-INDIVIDUAL DIFFERENCES IN OUTCOMES EXIST, WITH ROUGHLY 50% OF PATIENTS RESPONDING TO TREATMENT AND FEWER THAN THAT FULLY REMITTING. THIS GRANT SUPPORTED THE DEVELOPMENT OF A RESPONSE DIAGNOSTIC TEST BASED ON PRELIMINARY FINDINGS FOR A COMBINATION COGNITIVE/IMAGING MARKER RESULTING FROM CVB'S INVESTMENT IN THE COHEN VETERANS CENTER STUDY AT NYU/STANFORD. THE PROGRAM INCLUDED A CLINICAL STUDY AT TWO CENTERS OF OVER 200 SUBJECTS TO REPLICATE THE INITIAL FINDING, AND IS SEEKING QUALIFICATION VIA THE FOOD AND DRUG ADMINISTRATION ("FDA") GUIDANCE TO SUPPORT THE COMMERCIALIZATION AND/OR AVAILABILITY OF THE TEST FOR CLINICAL PRACTICE AND RESEARCH AND DEVELOPMENT. THIS STUDY COMPLETED RECRUITMENT IN DECEMBER 2019 AND SEMINAL RESULTS WHICH DEMONSTRATE THAT AN EEG BASED BIOMARKER CAN PREDICT TREATMENT RESPONSE FOR INDIVIDUALS WITH PTSD OR MDD WERE PUBLISHED IN 2020 AND 2021.IN 2022, WE CONDUCTED BIOMARKER ASSAYS ON BLOOD SAMPLES COLLECTED IN THE BEST STUDY PROGRAM TO LOOK FOR GENETIC AND INFLAMMATORY MARKERS THAT MAY BE PREDICTIVE OF RESPONSE AND/OR DISEASE.PTSD GENETICS PROGRAM:THE PSYCHIATRIC GENETICS CONSORTIUM-PTSD WORKING GROUP - BROAD INSTITUTE COLLABORATION IS SUPPORTING THE LARGEST GLOBAL GENOME WIDE ASSOCIATION STUDY ("GWAS") OF PTSD TO DATE WITH DATA FROM OVER 200,000 INDIVIDUALS ANALYZED. THE MAIN GOAL IS TO UNCOVER THE GENETIC UNDERPINNINGS OF PTSD RISK AND PUBLISH ALL RESULTS. SEMINAL FINDINGS OF THE FIRST PTSD GENETIC RISK LOCI FROM THIS PROGRAM WERE PUBLISHED IN NATURE COMMUNICATIONS IN OCTOBER 2019.IN 2022, THE GWAS PROGRAM HAS EXPANDED TO INCLUDE OVER 350,000 INDIVIDUALS WITH TRAUMA AND 2 MILLION HEALTH CONTROLS YIELDING >77 IDENTIFIED GENETIC RISK LOCI.PRISM2 (PSYCHIATRIC RATINGS USING INTERMEDIATE STRATIFIED MARKERS 2):IN 2021, WE JOINED THE INNOVATIVE MEDICINES INITIATIVE AND EUROPEAN FEDERATION OF PHARMACEUTICAL INDUSTRIES AND ASSOCIATIONS (EFPIA) AS A FUNDER AND COLLABORATOR IN THE PRISM2 STUDY PROGRAM. BUILDING ON THE SUCCESS OF INNOVATIVE RESEARCH BY THE PRISM PROJECT, THE INNOVATIVE MEDICINE INITIATIVE 2, A JOINT UNDERTAKING BETWEEN THE EU AND THE EUROPEAN FEDERATION OF PHARMACEUTICAL INDUSTRIES AND ASSOCIATIONS (EFPIA), HAS BACKED THE PROGRAM WITH FUNDING FOR A NEW PROJECT TO EXPLORE THE UNDERLYING BIOLOGY OF ALZHEIMER'S DISEASE, SCHIZOPHRENIA AND MAJOR DEPRESSIVE DISORDER (MDD). THE NEW PRISM 2 (PSYCHIATRIC RATINGS USING INTERMEDIATE STRATIFIED MARKERS 2) PROJECT AIMS TO IDENTIFY QUANTITATIVE BIOLOGICAL FEATURES COMMON ACROSS THE DISEASES, OPENING THE POSSIBILITY OF DEVELOPING TARGETED TREATMENTS IRRESPECTIVE OF TRADITIONAL DIAGNOSIS.PRISM WAS A PAN-EUROPEAN RESEARCH PROJECT THAT RAN FROM 2016 TO 2021 AND RECEIVED 16.5 MILLION FUNDING FROM THE INNOVATIVE MEDICINES INITIATIVE 2 JOINT UNDERTAKING UNDER GRANT AGREEMENT NO 115916, SUPPORTED BY THE EUROPEAN UNION'S HORIZON 2020 RESEARCH AND INNOVATION PROGRAMME AND EFPIA. THE RESULTS OF PRISM CONSTITUTE THE FOUNDATION FOR THE CURRENT PRISM 2 PROJECT.THE PRISM2 PROJECT LAUNCHED IN 2022, INCLUDING PATIENT ENROLLMENT OF INDIVIDUALS WITH SCHIZOPHRENIA, DEMENTIA OR MAJOR DEPRESSION ACROSS THREE CENTERS IN EUROPE.NATIONAL NORMATIVE NEUROIMAGING LIBRARY PROGRAM:CVB HAS CREATED AN IMAGING REFERENCE LIBRARY ESSENTIAL TO THE DEVELOPMENT OF EFFECTIVE CLINICAL IMAGING TOOLS FOR DIAGNOSING AND MANAGING PATIENTS WITH BRAIN DISORDERS. ADVANCED NEUROIMAGING CAN NOW DETECT MICROSCOPIC CHANGES IN BRAIN STRUCTURE CAUSED BY TRAUMA OR DISEASE. THESE ADVANCED IMAGING APPROACHES INCLUDE DIFFUSION TENSOR IMAGING ("DTI"), FUNCTIONAL CONNECTIVITY, PERFUSION WEIGHTED IMAGING, AND VOLUMETRIC IMAGING. DESPITE THEIR PROMISE, THESE ADVANCED APPROACHES ARE CURRENTLY PRIMARILY CONFINED TO RESEARCH USE. THE NUMERICAL NATURE OF THE INFORMATION THESE ADVANCED IMAGING APPROACHES YIELD IS DIFFICULT TO TRANSLATE FROM THE STUDY OF GROUPS OF INDIVIDUALS TO A SINGLE PATIENT WITHOUT A REFERENCE. THE IMAGING DATABASE IS BASED ON THE RESULTS OF A NATIONAL STUDY OF NORMATIVE INDIVIDUALS, SPONSORED BY CVB AT UNIVERSITY OF VIRGINIA, BAYLOR UNIVERSITY AND UNIVERSITY OF UTAH AND TWO MILITARY SITES. STANDARDIZED ADVANCED NEUROIMAGING SCANS ON 3,000 ADULT VOLUNTEERS, THE RESULTING IMAGING DATA, ALONG WITH DEMOGRAPHIC INFORMATION AND THE RESULTS OF NEUROCOGNITIVE ASSESSMENTS, IS FORMING A LIBRARY DOCUMENTING POPULATION VARIATION IN BRAIN STRUCTURE AND FUNCTION AS MEASURED BY THESE ADVANCED IMAGING METHODS.THROUGH THIS IMAGING DATABASE, IT IS OUR GOAL TO ADVANCE NEUROIMAGING TO DRAMATICALLY IMPROVE THE IDENTIFICATION OF AFFECTED INDIVIDUALS AND ALLOW PHYSICIANS TO OBJECTIVELY AND EFFICIENTLY DIAGNOSE CONDITIONS SUCH AS TBI, DEMENTIA AND OTHER BRAIN DISORDERS WHERE BRAIN STRUCTURE IS DETECTED VIA MRI.IN 2022, WE CONTINUED RECRUITMENT INTO THE LIBRARY REACHING >1800 ENROLLED SUBJECTS AND ALSO ADDED BLOOD SAMPLE COLLECTION FOR NEWLY RECRUITED INDIVIDUALS. COMPUTATIONAL MODELING & DATA SCIENCES:CVB HAS ESTABLISHED AN INTRAMURAL DATA SCIENCES PROGRAM TO BUILD MACHINE-LEARNING AND ARTIFICIAL INTELLIGENCE BASED PREDICTIVE MODELS OF DISEASE. THESE PROGRAMS BUILD ON OUR ORIGINAL ORION MS BIO-MODELLING PROGRAM AND FOCUSES ON MODELS OF PTSD, TBI, PARKINSONS AND DEMENTIA AND OTHER CONDITIONS.POST-TRAUMATIC STRESS DISORDER ("PSTD") 1.0:OUR MAIN PRIORITY IS TO BUILD A MULTI-MODAL MODEL OF PTSD USING DEEPLY-PHENOTYPED COHORTS SUCH AS THE BEST STUDY AND COHEN VETERANS CENTER STUDIES. IN 2022, WE HAVE BUILT ANALYSIS PIPELINES FOR EPIGENETIC, EEG, INFLAMMATORY MARKER AND CLINICAL DATA AND WE ARE ON TRACK TO BUILD OUR FIRST MODEL BY YEAR END.PARKINSON'S PROGRESSION MARKERS INITIATIVE ("PPMI") DATA SCIENCE MODELING GROUP:EXISTING DIAGNOSES FOR COMPLEX BRAIN DISORDERS SUCH AS PARKINSON'S DISEASE FOCUS ON UNDERSTANDING CLUSTERS OF MAJOR SYMPTOMS. IN ORDER TO DRIVE PROGRESS IN THE DEVELOPMENT OF NEW TREATMENTS IT IS IMPORTANT TO UNDERSTAND THE ROLE OF SPECIFIC BIOLOGICAL PROCESSES IN DETERMINING PATIENT OUTCOMES. IN THIS PROGRAM WE MODEL THE MICHAEL J. FOX FOUNDATION ("MJFF") SPONSORED PARKINSON'S PROGRESSION MODEL INITIATIVE STUDY. THE STUDY HAS EVALUATED PARTICIPANTS' CLINICAL STATUS WHILE COLLECTING IMAGING, BEHAVIORAL, 'OMICS AND OTHER ASSESSMENTS LONGITUDINALLY SINCE 2010. IN OUR ALIGNED MISSIONS TO ADVANCE BRAIN HEALTH, MJFF SELECTED CVB'S DATA SCIENCE TEAM TO LEVERAGE THIS COHORT TOGETHER WITH A MULTI-DISCIPLINARY APPROACH TO QUANTITATIVELY EXPLORE, EVALUATE, AND PREDICT DISEASE TRAJECTORY, RISK FACTORS, AND SUBTYPES. GIVEN THE BREADTH AND DEPTH OF THE PPMI DATA AND RICH OPPORTUNITIES TO DEVELOP IMPACTFUL DISEASE MODELS, THE TEAM USE THEIR SUBJECT MATTER EXPERTISE ACROSS TRANSLATIONAL SCIENCE TO GENERATE INSIGHTS FROM 'OMICS, IMAGING, GENETIC AND CLINICAL DATA BY INTEGRATING TECHNIQUES ACROSS ADVANCED STATISTICS, MACHINE LEARNING, AND COMPUTATIONAL MODELING TO FACILITATE PD BIOMARKER DISCOVERY AND DEEPEN OUR UNDERSTANDING OF DISEASE PROGRESSION.	Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

Field	Value	IRS element (for citing)
Desc	MULTIPLE SCLEROSIS ("MS") 1.0:THE ORION BIONETWORKS FLAGSHIP PROGRAM SUCCESSFULLY PILOTED THE ESTABLISHMENT OF A MULTIPLE SCLEROSIS BIONETWORK COMPRISED OF ACADEMIC (NEUROSCIENCE INSTITUTE OF THE BRIGHAM AND WOMEN'S HOSPITAL), ADVOCACY (ACCELERATED CURE PROJECT FOR MS), COMPUTATIONAL (GNS HEALTHCARE, METACELL, THOMSON REUTERS), INFORMATICS (CONVERGE BY DELOITTE, RANCHO BIOSCIENCES, EXAPTIVE), AND ONLINE PATIENT COMMUNITY PARTNERS (PATIENTSLIKEME [PLM]). DE-IDENTIFIED HIPPA-COMPLIANT DATA FROM THREE DATABASES WERE CURATED AND LOADED INTO A CLOUD-BASED DATA KNOWLEDGE MANAGEMENT SYSTEM. THE INTEGRATED REPOSITORY INCLUDES 9,000 SUBJECTS WITH MS AND RELATED CONDITIONS. THE ALLIANCE DEVELOPED A ROADMAP FOR JOINT EXECUTION WITH SPECIFIC SCIENTIFIC AIMS. THE ALLIANCE HAS GENERATED MULTIPLE MODELS BASED ON THE DATA REPOSITORY USING DIFFERENT ALGORITHMIC APPROACHES: PHENOTYPIC PROGNOSTIC MODEL AND TWO MOLECULAR PROGNOSTIC MODELS.PTSD AND TBI PRECLINICAL MODELING PROGRAM:ANIMAL MODELS OF PSYCHIATRIC DISORDERS OFFER A COMPLEMENTARY RESEARCH MODALITY THAT SUPPORTS CLINICAL RESEARCH. IN ORDER TO ACHIEVE A SATISFACTORY DEGREE OF VALIDITY AND RELIABILITY, ANIMAL MODELS OF COMPLEX AND INTRICATE PSYCHIATRIC DISORDERS, SUCH AS PTSD, MUST FULFILL CERTAIN CRITERIA: PATHOGENIC PROCESSES MUST BE OBSERVABLE AND MEASURABLE, AND MUST RELIABLY REFLECT CLINICAL SYMPTOMATOLOGY, AND PHARMACOLOGICAL AGENTS THAT ARE KNOWN TO AFFECT SYMPTOMS IN HUMAN SUBJECTS, SHOULD MODULATE THESE PROCESSES. CVB HAS ESTABLISHED THE ALLIANCE FOR MODELS OF PTSD, INNOVATIVE TECHNOLOGIES AND UNIFORM PRACTICES ("AMP-IT- UP") TO SUPPORT PRECLINICAL MODEL DEVELOPMENT. MULTIPLE SUB-GRANT AWARDS COMPLETED AND PUBLISHED THEIR FINDING THIS YEAR IN SUPPORT THE MISSION OF THIS PROGRAM.PEERS - THE PLATFORM FOR THE EXCHANGE OF EXPERIMENTAL RESEARCH STANDARDSPEERS IS A PLATFORM THAT ENABLES SHARING OF INFORMATION ON PARAMETERS THAT AFFECT THE ROBUSTNESS OF PRECLINICAL DATA. PEERS IS LIKE A WIKI ON HOW TO DESIGN, CONDUCT AND ANALYZE EXPERIMENTS TO INCREASE DATA ROBUSTNESS. PEERS ALLOWS USERS TO SEARCH FOR FACTORS AND PARAMETERS THAT ARE OF RELEVANCE TO THEIR EXPERIMENTS AND GIVES GUIDANCE AND ADVICE ON HOW TO LEVERAGE THESE FACTORS TO INCREASE THE QUALITY, ROBUSTNESS AND REPRODUCIBILITY OF RESEARCH. PEERS ALLOWS USERS TO: (1) SEARCH FOR FACTORS AND PARAMETERS THAT ARE OF RELEVANCE TO THEIR EXPERIMENTS (2) FIND RECOMMENDATIONS AND BEST PRACTICES ON EXPERIMENTAL DESIGN, EXECUTION AND DATA ANALYSIS FOR SPECIFIC IN VITRO METHODS OR IN VIVO MODELS (3) SHARE EXPERIENCES AND KNOWLEDGE TO HELP OTHERS BUILD HIGH-QUALITY, REPRODUCIBLE DATA SETS (4) CITE CONTRIBUTIONS (5) INCREASE THE QUALITY, ROBUSTNESS AND REPRODUCIBILITY OF RESEARCH.ADDRESSING SEX AS A BIOLOGICAL VARIABLE IN PRECLINICAL RESEARCH:DIFFERENCES BETWEEN MALES AND FEMALES EXTEND WELL BEYOND REPRODUCTION, WITH SIGNIFICANT IMPLICATIONS FOR HUMAN HEALTH AND DISEASE. THIS IS PARTICULARLY THE CASE IN THE FIELD OF NEUROSCIENCE, WHERE DIFFERENCES IN BASIC BIOLOGY BETWEEN MEN AND WOMEN CAN LEAD TO SEX DIFFERENCES IN THE PREVALENCE, PROGRESSION, AND RESPONSES TO TREATMENT OF MANY BRAIN DISORDERS.THIS VIDEO TRAINING SERIES WAS DEVELOPED AND LAUNCHED BY COHEN VETERANS BIOSCIENCE IN 2022, TO ENSURE THAT EARLY-STAGE RESEARCH IS CONDUCTED TO THE HIGHEST AND MOST RIGOROUS STANDARDS POSSIBLE. ONE SOLUTION IS TO ENSURE THAT THE RESEARCH COMMUNITY-INCLUDING GRADUATE STUDENTS, POSTDOCS, AND OTHER EARLY CAREER RESEARCHERS-HAVE THE TOOLS THEY NEED TO ENABLE THE IMPLEMENTATION OF BEST PRACTICES ACROSS THE EXPERIMENTAL PROCESS. THE GOAL OF THE VIDEO TRAINING SERIES, WHICH CONTAINS THREE MODULES, WAS TO PROVIDE PRACTICAL GUIDANCE TO PRECLINICAL RESEARCHERS ON HOW TO NAVIGATE THE NIH'S 2015 POLICY ON INCORPORATING SEX AS A BIOLOGICAL VARIABLE INTO THEIR CURRENT AND FUTURE RESEARCH.GLOBAL PRECLINICAL DATA FORUM:THE GLOBAL PRECLINICAL DATA FORUM ("GPDF") IS A JOINTLY SPONSORED U.S. AND EUROPEAN INITIATIVE THAT ENCOURAGES GLOBAL COLLABORATION TO ADDRESS THE CHALLENGE OF ENSURING THAT PRECLINICAL RESEARCH IS REPRODUCIBLE, ROBUST AND TRANSLATABLE TO SUPPORT DISEASE RESEARCH UTILITY FOR CLINICAL RESEARCH & DEVELOPMENT ("R&D"). IT SUPPORTS BEST RESEARCH PRACTICES, THE DEVELOPMENT AND IMPLEMENTATION OF DATA QUALITY STANDARDS, PRECLINICAL DATA & TECHNOLOGICAL PLATFORMS, AND TRAINING PROGRAMS FOR THE NEUROSCIENCE COMMUNITY WITH THE GOAL OF ENHANCING THE DATA UTILITY DERIVED FROM PRECLINICAL MODELS.THIS IS OUR FIFTH YEAR SUPPORTING, WITH THE EUROPEAN COLLEGE OF NEUROPHARMACOLOGY ("ECNP"), THE WORLD'S FIRST NEGATIVE DATA PRIZE AS AN INCENTIVE FOR PRECLINICAL RESEARCHERS TO PUBLISH "NEGATIVE DATA" RESULTS TO ENSURE ALL NEUROSCIENCE STUDIES PROPERLY ADVANCE KNOWLEDGE. THE PRIZE IS AWARDED TO THE RESEARCHER OR RESEARCH GROUP WHOSE NEUROSCIENCE STUDY BEST EXEMPLIFIES DATA WHERE THE OUTCOMES DO NOT CONFIRM THE EXPECTED RESULTS OR WORKING HYPOTHESIS. THE PRECLINICAL AWARD WAS PRESENTED DURING THE 2020 VIRTUAL ECNP CONFERENCE.IN 2022 WE CONTINUED TO AWARD THE BEST NEGATIVE PRIZE AWARDS PROGRAM TO CLINICAL RESEARCHERS WHOSE NEUROSCIENCE STUDY BEST EXEMPLIFIES DATA WHERE THE OUTCOMES DO NOT CONFIRM THE EXPECTED RESULTS OR WORKING HYPOTHESIS.EQIPD QUALITY SYSTEM:THE GPDF AND COHEN VETERANS BIOSCIENCE ARE BOTH MAJOR CONTRIBUTORS TO THE EUROPEAN UNION INNOVATIVE MEDICINE INITIATIVE-FUNDED CONSORTIUM CALLED EQIPD (EQIPD.ORG). THE EQIPD CONSORTIUM HAS DEVELOPED A NOVEL PRECLINICAL RESEARCH QUALITY SYSTEM THAT CAN BE APPLIED IN BOTH PUBLIC AND PRIVATE SECTORS AND IS FREE FOR ANYONE TO USE. THE EQIPD QUALITY SYSTEM WAS DESIGNED TO BE SUITED TO BOOST INNOVATION BY ENSURING THE GENERATION OF ROBUST AND RELIABLE PRECLINICAL DATA WHILE BEING LEAN, EFFECTIVE AND NOT BECOMING A BURDEN THAT COULD NEGATIVELY IMPACT THE FREEDOM TO EXPLORE SCIENTIFIC QUESTIONS. EQIPD DEFINES RESEARCH QUALITY AS THE EXTENT TO WHICH RESEARCH DATA ARE FIT FOR THEIR INTENDED USE. FITNESS, IN THIS CONTEXT, IS DEFINED BY THE STAKEHOLDERS, WHO ARE THE SCIENTISTS DIRECTLY INVOLVED IN THE RESEARCH, BUT ALSO THEIR FUNDERS, SPONSORS, PUBLISHERS, RESEARCH TOOL MANUFACTURERS AND COLLABORATION PARTNERS SUCH AS PEERS IN A MULTI-SITE RESEARCH PROJECT. THE ESSENCE OF THE EQIPD QUALITY SYSTEM IS THE SET OF 18 CORE REQUIREMENTS THAT CAN BE ADDRESSED FLEXIBLY, ACCORDING TO USER-SPECIFIC NEEDS AND FOLLOWING A USER-DEFINED TRAJECTORY. THE EQIPD QUALITY SYSTEM PROPOSES GUIDANCE ON EXPECTATIONS FOR QUALITY-RELATED MEASURES, DEFINES CRITERIA FOR ADEQUATE PROCESSES (I.E., PERFORMANCE STANDARDS) AND PROVIDES EXAMPLES OF HOW SUCH MEASURES CAN BE DEVELOPED AND IMPLEMENTED. IN 2022, WE THE GUARANTORS GROUP FOR THE EQIPD SOCIETY HAS DEVELOPED A COMMUNICATION AND BUSINESS PLAN FOR THE ADOPTION OF CERTIFICATION BY USERS TO IMPROVE RESEARCH. POLICY & ADVOCACY INITIATIVES:WE ARE COMMITTED TO ADVOCATING FOR POLICY REFORMS AT THE FEDERAL LEVEL THAT BUILD UPON EVIDENCE-BASED PRECISION MEDICINE APPROACHES AND HAVE THE POWER TO BRING NEW SOLUTIONS FOR PTSD AND TBI IN YEARS, NOT DECADES. AS PART OF OUR ADVOCACY EFFORTS, WE CO-FOUNDED THE COALITION TO HEAL INVISIBLE WOUNDS (THE "COALITION"), A COLLABORATIVE INITIATIVE AIMED AT ADVOCATING FOR POLICY REFORMS TO WIDEN AND EXPEDITE THE PIPELINE FOR NEW THERAPIES AND DIAGNOSTICS FOR PTSD AND TBI - WHICH CAN BOTH DRASTICALLY INCREASE THE RISK OF SUICIDE AMONG VETERANS. IN 2022, OUR CVB POLICY HEAD WAS INVITED TO JOIN THE BOARD OF THE AMERICAN BRAIN COALITION TO HELP GUIDE ITS NATIONAL LEVEL BRAIN POLICY EFFORTS.	Desc

Field	Value	IRS element (for citing)
Total Program Service Expenses	$14,959,934	TotalProgramServiceExpensesAmt
Described In Section501c3	Yes (1)	DescribedInSection501c3Ind
Schedule B Required	Yes (1)	ScheduleBRequiredInd
Political Campaign Acty	0	PoliticalCampaignActyInd
Lobbying Activities	Yes (1)	LobbyingActivitiesInd
Subject To Proxy Tax	0	SubjectToProxyTaxInd
Donor Advised Fund	0	DonorAdvisedFundInd
Conservation Easements	0	ConservationEasementsInd
Collections Of Art	0	CollectionsOfArtInd
Credit Counseling	0	CreditCounselingInd
Donor Rstr Or Quasi Endowments	0	DonorRstrOrQuasiEndowmentsInd
Report Land Building Equipment	Yes (1)	ReportLandBuildingEquipmentInd
Report Investments Other Sec	0	ReportInvestmentsOtherSecInd
Report Program Related Invst	0	ReportProgramRelatedInvstInd
Report Other Assets	Yes (1)	ReportOtherAssetsInd
Report Other Liabilities	Yes (1)	ReportOtherLiabilitiesInd
Include FIN48 Footnote	Yes (1)	IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt	Yes (1)	IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt	0	ConsolidatedAuditFinclStmtInd
School Operating	0	SchoolOperatingInd
Foreign Office	Yes (1)	ForeignOfficeInd
Foreign Activities	Yes (1)	ForeignActivitiesInd
More Than5000 K To Org	Yes (1)	MoreThan5000KToOrgInd
More Than5000 K To Individuals	0	MoreThan5000KToIndividualsInd
Professional Fundraising	Yes (1)	ProfessionalFundraisingInd
Fundraising Activities	0	FundraisingActivitiesInd
Gaming Activities	0	GamingActivitiesInd
Operate Hospital	0	OperateHospitalInd
Grants To Organizations	Yes (1)	GrantsToOrganizationsInd
Grants To Individuals	0	GrantsToIndividualsInd
Schedule J Required	Yes (1)	ScheduleJRequiredInd
Tax Exempt Bonds	0	TaxExemptBondsInd
Engaged In Excess Benefit Trans	0	EngagedInExcessBenefitTransInd
PY Excess Benefit Trans	0	PYExcessBenefitTransInd
Loan Outstanding	0	LoanOutstandingInd
Grant To Related Person	0	GrantToRelatedPersonInd
Business Rln With Org Mem	0	BusinessRlnWithOrgMemInd
Business Rln With Fam Mem	0	BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent	0	BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri	0	DeductibleNonCashContriInd
Deductible Art Contribution	0	DeductibleArtContributionInd
Terminate Operations	0	TerminateOperationsInd
Partial Liquidation	0	PartialLiquidationInd
Disregarded Entity	Yes (1)	DisregardedEntityInd
Related Entity	0	RelatedEntityInd
Related Organization Ctrl Ent	0	RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org	0	TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp	0	ActivitiesConductedPrtshpInd
Schedule O Required	Yes (1)	ScheduleORequiredInd
IRP Document	45	IRPDocumentCnt
IRP Document W2 G	0	IRPDocumentW2GCnt
Employee	46	EmployeeCnt
Employment Tax Returns Filed	Yes (1)	EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit	0	UnrelatedBusIncmOverLimitInd
Foreign Financial Account	0	ForeignFinancialAccountInd
Prohibited Tax Shelter Trans	0	ProhibitedTaxShelterTransInd
Taxable Party Notification	0	TaxablePartyNotificationInd
Nondeductible Contributions	0	NondeductibleContributionsInd
Quid Pro Quo Contributions	0	QuidProQuoContributionsInd
Form8282 Property Disposed Of	0	Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct	0	RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct	0	PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services	0	IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt	0	SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc	0	SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VI	Yes (X)	InfoInScheduleOPartVIInd
Governing Body Voting Members	5	GoverningBodyVotingMembersCnt
Independent Voting Member	4	IndependentVotingMemberCnt
Family Or Business Rln	0	FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties	0	DelegationOfMgmtDutiesInd
Change To Org Documents	0	ChangeToOrgDocumentsInd
Material Diversion Or Misuse	0	MaterialDiversionOrMisuseInd
Members Or Stockholders	0	MembersOrStockholdersInd
Election Of Board Members	0	ElectionOfBoardMembersInd
Decisions Subject To Approva	0	DecisionsSubjectToApprovaInd
Minutes Of Governing Body	Yes (1)	MinutesOfGoverningBodyInd
Minutes Of Committees	Yes (1)	MinutesOfCommitteesInd
Officer Mailing Address	0	OfficerMailingAddressInd
Local Chapters	0	LocalChaptersInd
Form990 Provided To Gvrn Body	Yes (1)	Form990ProvidedToGvrnBodyInd
Conflict Of Interest Policy	Yes (1)	ConflictOfInterestPolicyInd
Annual Disclosure Covered Prsn	Yes (1)	AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc	Yes (1)	RegularMonitoringEnfrcInd
Whistleblower Policy	Yes (1)	WhistleblowerPolicyInd
Document Retention Policy	Yes (1)	DocumentRetentionPolicyInd
Compensation Process CEO	Yes (1)	CompensationProcessCEOInd
Compensation Process Other	Yes (1)	CompensationProcessOtherInd
Investment In Joint Venture	0	InvestmentInJointVentureInd
States Where Copy Of Return Is Fld	MA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	DC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	FL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	GA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	HI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	IL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MD	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NJ	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	PA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	RI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	SC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	TN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	UT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	VA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WV	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WI	StatesWhereCopyOfReturnIsFldCd
Other Website	Yes (X)	OtherWebsiteInd
Upon Request	Yes (X)	UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	GELMAN ROSENBERG AND FREEDMAN CPA	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Phone	3019519090	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	4550 MONTGOMERY AVENUE SUITE 650N	AddressLine1Txt
City	BETHESDA	CityNm
State Abbreviation	MD	StateAbbreviationCd
ZIP	20814	ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (16 entries)

TitleTitleTxt	Average Hours Per WeekAverageHoursPerWeekRt	Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd	OfficerOfficerInd	Reportable Comp From OrgReportableCompFromOrgAmt	Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt	Other CompensationOtherCompensationAmt	Key EmployeeKeyEmployeeInd	Highest Compensated EmployeeHighestCompensatedEmployeeInd
MAGALI HAAS MD PHD
CEO & PRESIDENT	60.00	Yes (X)	Yes (X)	$630,807	$0	$25,999
THERESA FRANGIOSA
SECRETARY	9.00	Yes (X)	Yes (X)	$0	$0	$0
MICHAEL SULLIVAN
TREASURER	1.00	Yes (X)	Yes (X)	$0	$0	$0
DAVID BIONDI
BOARD MEMBER	1.00	Yes (X)		$0	$0	$0
DOUGLAS HAYNES
FORMER BOARD MEMBER	1.00	Yes (X)		$0	$0	$0
DAVE DEMARCO
BOARD MEMBER	1.00	Yes (X)		$0	$0	$0
ANDREAS JEROMIN PHD
CHIEF SCIENTIFIC OFFICER	40.00			$433,741	$0	$31,076	Yes (X)
LEE LANCASHIRE
CHIEF INFORMATION OFFICER	40.00			$340,407	$0	$95,841	Yes (X)
ALLYSON GAGE PHD
CHIEF MEDICAL OFFICER	40.00			$492,702	$0	$38,412	Yes (X)
AMANDA NICOLE HARMON
CHIEF OPERATIONS OFFICER	40.00			$282,489	$0	$48,736	Yes (X)
EVGENY RAKHMATULIN
CHIEF TECHNOLOGY OFFICER	40.00			$323,355	$0	$55,935	Yes (X)
KERSTEN SMALL
DEPUTY DIRECTOR, TRANSLATIONAL RND	40.00			$260,970	$0	$51,937		Yes (X)
LAUREN GOLDSMITH
SENIOR DIRECTOR, CONTRACTS	40.00			$217,861	$0	$25,589		Yes (X)
MARK ZERVAS
DEPUTY DIRECTOR, TRANSLATIONAL SCIENCE	40.00			$177,660	$0	$43,678		Yes (X)
MARYAN ZIRKLE
EXECUTIVE DIRECTOR, BRAINCOMMONS	40.00			$280,815	$0	$29,396		Yes (X)
RENEE DAVIS
EXECUTIVE DIRECTOR, DEVELOPMENT	40.00			$282,286	$0	$29,572		Yes (X)

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	$3,723,093	TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org	$0	TotReportableCompRltdOrgAmt
Total Other Compensation	$476,171	TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K	20	IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed	0	FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K	Yes (1)	TotalCompGreaterThan150KInd
Compensation From Other Srcs	0	CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1Txt	CityContractorAddress/USAddress/CityNm	State AbbreviationContractorAddress/USAddress/StateAbbreviationCd	ZIPContractorAddress/USAddress/ZIPCd	ServicesServicesDesc	CompensationCompensationAmt	Address Line1ContractorAddress/ForeignAddress/AddressLine1Txt	CityContractorAddress/ForeignAddress/CityNm	CountryContractorAddress/ForeignAddress/CountryCd	Foreign PostalContractorAddress/ForeignAddress/ForeignPostalCd
HITACHI VANTARA LLC
2535 AUGUSTINE DRIVE	SANTA CLARA	CA	950543003	CLOUD-BASED ARCHITECTURE BUILD AND MANAG	$861,974
WAVEACCESS USA
10161 WEST RUN PARK DRIVE SUITE 15	LAS VEGAS	NV	89145	RESOURCES FOR BRAIN COMMONS AND EARLY SI	$701,210
GRF CPA'S & ADVISORS
				ACCOUNTING AND BOOKKEEPING	$321,233	4550 MONTGOMERY AVENUE SUITE 800	NORTH BETHESDA	UK	20814
MORGAN LEWIS AND BOCKIUS LLP
1701 MARKET STREET	PHILADELPHIA	PA	19103	LEGAL SERVICES	$273,913
TONE CREATIVE LLC
63 PUTNAM STREET SUITE 202	SARASOTA SPRINGS	NY	12866	MARKETING AND DESIGN SERVICES	$239,234

Field	Value	IRS element (for citing)
Cntrct Rcvd Greater Than100 K	15	CntrctRcvdGreaterThan100KCnt
Government Grants	$84,219	GovernmentGrantsAmt
All Other Contributions	$17,856,836	AllOtherContributionsAmt
Total Contributions	$17,941,055	TotalContributionsAmt

Investment Income InvestmentIncomeGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$28,608	TotalRevenueColumnAmt
Exclusion	$28,608	ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp (2 entries)

DescDesc	BusinessBusinessCd	Total Revenue ColumnTotalRevenueColumnAmt	Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt
OTHER REFUNDS	900099	$110,255	$110,255
STIMULUS/COVID CREDITS	900099	$2,480	$2,480

Field	Value	IRS element (for citing)
Other Revenue Total	$112,735	OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$18,082,398	TotalRevenueColumnAmt
Related Or Exempt Func Income	$112,735	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$28,608	ExclusionAmt

Field	Value	IRS element (for citing)
Info In Schedule O Part IX	Yes (X)	InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

Field	Value	IRS element (for citing)
Total	$235,883	TotalAmt
Program Services	$235,883	ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

Field	Value	IRS element (for citing)
Total	$265,464	TotalAmt
Program Services	$265,464	ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

Field	Value	IRS element (for citing)
Total	$2,791,488	TotalAmt
Program Services	$2,362,364	ProgramServicesAmt
Management And General	$271,713	ManagementAndGeneralAmt
Fundraising	$157,411	FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

Field	Value	IRS element (for citing)
Total	$3,867,496	TotalAmt
Program Services	$3,030,776	ProgramServicesAmt
Management And General	$502,979	ManagementAndGeneralAmt
Fundraising	$333,741	FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

Field	Value	IRS element (for citing)
Total	$228,673	TotalAmt
Program Services	$185,645	ProgramServicesAmt
Management And General	$27,541	ManagementAndGeneralAmt
Fundraising	$15,487	FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

Field	Value	IRS element (for citing)
Total	$324,554	TotalAmt
Program Services	$260,160	ProgramServicesAmt
Management And General	$38,297	ManagementAndGeneralAmt
Fundraising	$26,097	FundraisingAmt

Payroll Taxes PayrollTaxesGrp

Field	Value	IRS element (for citing)
Total	$335,122	TotalAmt
Program Services	$270,050	ProgramServicesAmt
Management And General	$39,882	ManagementAndGeneralAmt
Fundraising	$25,190	FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

Field	Value	IRS element (for citing)
Total	$160,307	TotalAmt
Management And General	$160,307	ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

Field	Value	IRS element (for citing)
Total	$347,569	TotalAmt
Management And General	$347,569	ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

Field	Value	IRS element (for citing)
Total	$90,000	TotalAmt
Program Services	$90,000	ProgramServicesAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

Field	Value	IRS element (for citing)
Total	$36,000	TotalAmt
Fundraising	$36,000	FundraisingAmt

Fees For Services Other FeesForServicesOtherGrp

Field	Value	IRS element (for citing)
Total	$6,681,925	TotalAmt
Program Services	$6,458,003	ProgramServicesAmt
Management And General	$204,798	ManagementAndGeneralAmt
Fundraising	$19,124	FundraisingAmt

Office Expenses OfficeExpensesGrp

Field	Value	IRS element (for citing)
Total	$380,242	TotalAmt
Program Services	$202,778	ProgramServicesAmt
Management And General	$164,157	ManagementAndGeneralAmt
Fundraising	$13,307	FundraisingAmt

Information Technology InformationTechnologyGrp

Field	Value	IRS element (for citing)
Total	$560,801	TotalAmt
Program Services	$541,448	ProgramServicesAmt
Management And General	$17,001	ManagementAndGeneralAmt
Fundraising	$2,352	FundraisingAmt

Occupancy OccupancyGrp

Field	Value	IRS element (for citing)
Total	$527,718	TotalAmt
Program Services	$451,160	ProgramServicesAmt
Management And General	$76,530	ManagementAndGeneralAmt
Fundraising	$28	FundraisingAmt

Travel TravelGrp

Field	Value	IRS element (for citing)
Total	$374,153	TotalAmt
Program Services	$343,973	ProgramServicesAmt
Management And General	$28,239	ManagementAndGeneralAmt
Fundraising	$1,941	FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

Field	Value	IRS element (for citing)
Total	$81,051	TotalAmt
Program Services	$81,051	ProgramServicesAmt

Depreciation Depletion DepreciationDepletionGrp

Field	Value	IRS element (for citing)
Total	$110,339	TotalAmt
Program Services	$101,964	ProgramServicesAmt
Management And General	$5,133	ManagementAndGeneralAmt
Fundraising	$3,242	FundraisingAmt

Insurance InsuranceGrp

Field	Value	IRS element (for citing)
Total	$124,999	TotalAmt
Program Services	$79,215	ProgramServicesAmt
Management And General	$38,396	ManagementAndGeneralAmt
Fundraising	$7,388	FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

Field	Value	IRS element (for citing)
Total	$17,523,784	TotalAmt
Program Services	$14,959,934	ProgramServicesAmt
Management And General	$1,922,542	ManagementAndGeneralAmt
Fundraising	$641,308	FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

Field	Value	IRS element (for citing)
BOY	$654,129	BOYAmt
EOY	$999,648	EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

Field	Value	IRS element (for citing)
BOY	$11,484,429	BOYAmt
EOY	$3,831,713	EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$4,776,718	BOYAmt
EOY	$8,295,108	EOYAmt

Accounts Receivable AccountsReceivableGrp

Field	Value	IRS element (for citing)
EOY	$21,300	EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

Field	Value	IRS element (for citing)
BOY	$268,785	BOYAmt
EOY	$123,073	EOYAmt

Field	Value	IRS element (for citing)
Land Bldg Equip Cost Or Other Bss	$1,628,960	LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec	$196,040	LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

Field	Value	IRS element (for citing)
BOY	$234,254	BOYAmt
EOY	$1,432,920	EOYAmt

Other Assets Total OtherAssetsTotalGrp

Field	Value	IRS element (for citing)
BOY	$534,269	BOYAmt
EOY	$883,589	EOYAmt

Total Assets TotalAssetsGrp

Field	Value	IRS element (for citing)
BOY	$17,952,584	BOYAmt
EOY	$15,587,351	EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

Field	Value	IRS element (for citing)
BOY	$2,078,653	BOYAmt
EOY	$2,682,753	EOYAmt

Grants Payable GrantsPayableGrp

Field	Value	IRS element (for citing)
BOY	$4,606,870	BOYAmt
EOY	$877,731	EOYAmt

Other Liabilities OtherLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$141,000	BOYAmt
EOY	$139,342	EOYAmt

Total Liabilities TotalLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$6,826,523	BOYAmt
EOY	$3,699,826	EOYAmt

Field	Value	IRS element (for citing)
Organization Follows FASB117	Yes (X)	OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$3,420,094	BOYAmt
EOY	$7,257,190	EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$7,705,967	BOYAmt
EOY	$4,630,335	EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$11,126,061	BOYAmt
EOY	$11,887,525	EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$17,952,584	BOYAmt
EOY	$15,587,351	EOYAmt

Field	Value	IRS element (for citing)
Info In Schedule O Part XI	Yes (X)	InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss	$558,614	ReconcilationRevenueExpnssAmt
Other Changes In Net Assets	$202,850	OtherChangesInNetAssetsAmt
Info In Schedule O Part XII	Yes (X)	InfoInScheduleOPartXIIInd
Method Of Accounting Accrual	Yes (X)	MethodOfAccountingAccrualInd
Accountant Compile Or Review	0	AccountantCompileOrReviewInd
FS Audited	Yes (1)	FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

Field	Value	IRS element (for citing)
Separate Basis Fincl Stmt	Yes (X)	SeparateBasisFinclStmtInd

Field	Value	IRS element (for citing)
Audit Committee	Yes (1)	AuditCommitteeInd
Federal Grant Audit Required	0	FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Public Organization170	Yes (X)	PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$16,828,176	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$20,795,052	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$16,316,026	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$16,160,581	CurrentTaxYearMinus1YearAmt
Current Tax Year	$17,941,055	CurrentTaxYearAmt
Total	$88,040,890	TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$16,828,176	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$20,795,052	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$16,316,026	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$16,160,581	CurrentTaxYearMinus1YearAmt
Current Tax Year	$17,941,055	CurrentTaxYearAmt
Total	$88,040,890	TotalAmt

Field	Value	IRS element (for citing)
Substantial Contributors Tot	$79,647,113	SubstantialContributorsTotAmt
Public Support Total170	$8,393,777	PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$17,365	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$98,872	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$154,639	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$59,585	CurrentTaxYearMinus1YearAmt
Current Tax Year	$28,608	CurrentTaxYearAmt
Total	$359,069	TotalAmt

Other Income170 OtherIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus1 Year	$32,104	CurrentTaxYearMinus1YearAmt
Current Tax Year	$112,735	CurrentTaxYearAmt
Total	$144,839	TotalAmt

Field	Value	IRS element (for citing)
Total Support	$88,544,798	TotalSupportAmt
Public Support CY170	0.09480	PublicSupportCY170Pct
Public Support PY170	0.11080	PublicSupportPY170Pct
Ten Pct Facts Crcmstncs Test PY	Yes (X)	TenPctFactsCrcmstncsTestPYInd
Facts And Circumstances Test	COHEN VETERANS BIOSCIENCE, INC. ("CVB") IS A PUBLIC CHARITY BIOMEDICAL RESEARCH AND TECHNOLOGY ORGANIZATION DEDICATED TO ADVANCING BRAIN HEALTH BY FAST-TRACKING PRECISION DIAGNOSTICS AND TAILORED THERAPEUTICS. WE ARE LEADING THE WAY TO CURE INVISIBLE WOUNDS FOR THE MILLIONS OF VETERANS, SERVICE MEMBERS, FIRST RESPONDERS, AND CIVILIANS WHO SUFFER FROM TRAUMA-RELATED CONDITIONS, SUCH AS PTSD, TBI AND SUICIDE. GLOBALLY, 2 BILLION INDIVIDUALS ARE DIRECTLY AFFECTED BY BRAIN DISORDERS. THE WORLD HEALTH ORGANIZATION ATTRIBUTES 38% OF THE TOTAL YEARS LOST TO DEATH AND DISABILITY TO BRAIN DISORDERS, A FIGURE WELL AHEAD OF THE NEXT-CLOSEST AND HIGHER-PROFILE DISEASES OF CANCER (12.7%) AND CARDIOVASCULAR DISEASE (11.8%). CVB IS CATALYZING RESEARCH TO ADVANCE BRAIN HEALTH AT ALL STAGES OF SCIENTIFIC DISCOVERY-FROM THEORY TO THERAPEUTIC.THIS MEMO PROVIDES EVIDENCE OF QUANTITATIVE AND QUALITATIVE MEASURES WHICH SUPPORT CONTINUED PUBLIC CHARITY STATUS. CVB MET THE QUANTITATIVE PERCENTAGE TEST CRITERION FOR SUPPORTING FACTS AND CIRCUMSTANCES IN FY21. CVB ENGAGES WITH AND MAKES AVAILABLE TO RESEARCHERS, POLICY MAKERS, AND THE GENERAL PUBLIC A BROAD ARRAY OF PROGRAMS, TOOLS, SERVICES, AND INFORMATION WHICH ADVANCE THE STATE OF BRAIN SCIENCE, GUIDED BY AN INDEPENDENT BOARD AND ADVISORY COUNSELS IN CONJUNCTION WITH CVB'S RENOWNED EXPERTS IN RELEVANT FIELDS OF NEUROSCIENCE, DATA SCIENCE AND PHARMACEUTICAL RESEARCH AND DEVELOPMENT. FOLLOWING ARE MORE DETAILED EVIDENCE OF THESE FACTS AND CIRCUMSTANCES. COHEN VETERANS BIOSCIENCE, INC. EARLY ORIGINS WERE AS AN ORGANIZATION UNDER THE FISCAL SPONSORSHIP OF THE MARIN COUNTY COMMUNITY FOUNDATION, LATER ESTABLISHED AS A STAND-ALONE 501(C)3 IN 2014 UNDER THE NAME ORION BIONETWORKS. CVB'S FOUNDER AND CEO HAS A PERSONAL CONNECTION TO THE PUBLIC WORK THE ORGANIZATION CARRIES OUT BY VIRTUE OF HER HUSBAND BEING A VETERAN OF THE US AIRFORCE SERVICE AND HER SISTER SERVING AS AN AIRFORCE COLONEL, WITH ACTIVE DEPLOYMENTS TO OEF/OIF. THE FORMAL NAME CHANGE TO COHEN VETERANS BIOSCIENCE TOOK PLACE IN 2015 IN CONCERT WITH GENEROUS SEED FUNDING FROM STEVEN A. COHEN. CVB QUALIFIES AS A PUBLIC CHARITY UNDER THE "FACTS AND CIRCUMSTANCES" TEST OF 1.170A-9(F)(3) OF THE TREASURY REGULATIONS, BASED UPON THE FOLLOWING:CVB IS ORGANIZED AND OPERATED SO AS TO ATTRACT NEW AND ADDITIONAL FUNDING ON A CONTINUOUS AND BONA FIDE BASIS; CVB HAS HAD A DONATION BUTTON ON ITS WEBSITE AND ALL SOCIAL MEDIA SINCE INCEPTION. AS OF FY22, WE HAVE ESTABLISHED REGISTERED STATUS ACROSS ALL 50 STATES. THE ORGANIZATION RUNS SEVERAL ONLINE DONATION CAMPAIGNS THROUGHOUT THE YEAR (E.G. MEMORIAL DAY, VETERENS DAY, GIVING DAY). IN FY22 WE HAVE AUGMENTED THIS WITH THE ESTABLISHMENT OF AN AMBASSADOR'S PROGRAM WHICH PROVIDES A "CROWDSOURCED" APPROACH WHERE INDIVIDUALS AND OTHER NONPROFIT INSTITUTIONS RAISE DONATIONS TO SUPPORT OUR MISSION. WE HAVE ALSO EXPANDED OUR CONDUCT OF FUNDRAISING EVENTS AT MAJOR EVENTS, E.G. COLFAX MARATHON IN DENVER. THE ORGANIZATION HAS ACTIVELY PURSUED AND RECEIVED GRANTS FROM GOVERNMENT AND PUBLIC CHARITIES AND FOUNDATIONS FOCUSED ON BRAIN DISEASES. IN CVB'S EARLY YEARS OF EXISTENCE THE SCOPE OF ITS SOLICITATION WAS MORE LIMITED TO PERSONS DEEMED MOST LIKELY TO PROVIDE EARLY FUNDING IN AN AMOUNT SUFFICIENT TO ENABLE IT TO COMMENCE ITS CHARITABLE ACTIVITIES AND EXPAND THE SOLICITATION PROGRAM. DIRECT OUTREACH TO POTENTIAL SUPPORTERS IS INCREASINGLY CONDUCTED BY CVB'S CEO AND OTHER EXECUTIVE TEAM AND SCIENTIFIC STAFF. CVB NOW REGULARLY CONDUCTS BROAD OUTREACH CAMPAIGNS, HAS STAFF DEDICATED TO FUNDRAISING AND SUPPORTER ENGAGEMENT TO SOLICIT CHARITABLE CONTRIBUTIONS FROM THE GENERAL PUBLIC, AND CARRIES ON ACTIVITIES DESIGNED TO ATTRACT SUPPORT FROM GOVERNMENT SOURCES AND PUBLIC CHARITIES. IN 2022, WE LAUNCHED AN ANNUAL MEMBERSHIP PROGRAM WITH OTHER NONPROFIT FOUNDATIONS, UNDER OUR COALITION TO HEAL INVISIBLE WOUNDS, TO SUPPORT ADVOCACY AND EDUCATION INITIATIVES.CVB HAS RECEIVED SUPPORT FROM A DIVERSITY OF DONORS AND SOURCES DURING ITS INITIAL START-UP PERIOD AND WILL CONTINUE TO EXPAND ITS DONOR BASE. DONORS INCLUDE US GOVERNMENT AGENCIES SUCH AS THE NATIONAL INSTITUTES OF HEALTH AND THE DEPARTMENT OF DEFENSE; A NUMBER OF NONPROFIT ORGANIZATIONS AND FOUNDATIONS INTERESTED IN MEDICAL RESEARCH AND ISSUES IMPACTING VETERANS; AND MORE THAN 100 INDIVIDUAL DONORS. CVB'S CURRENT FUNDRAISING PLANS ARE TARGETED AT A BROAD BASE OF DONORS, INCLUDING FOUNDATIONS, INDIVIDUALS, AND GOVERNMENT AGENCIES. STARTING IN 2020, WE ALSO ENGAGED IN PARTNERSHIPS WITH VETERANS SERVICE ORGANIZATIONS WHO HAVE COMMITTED TO RAISE AWARENESS OF INDIVIDUALLY DRIVEN FUNDRAISING CAMPAIGNS FOR VETERANS PTSD, TBI AND SUICIDE.AS EVIDENCED BY THE EXTENSIVE PROGRAMS SPONSORED BY CVB SUPPORTING RESEARCH COLLABORATIONS AND SCIENTIFIC BEST PRACTICE ADOPTION, CVB REMAINS AN ORGANIZATION COMMITTED TO SERVING THE PUBLIC THROUGH ITS WORK. EXAMPLES WHICH DEMONSTRATE OUR COMMITMENT TO THE PUBLIC BENEFIT AND PUBLIC PARTICIPATION IN OUR EFFORTS INCLUDE CVB'S VETERANS ADVISORY COUNCIL, STATE OF THE SCIENCE SUMMITS, NUMEROUS EXPERT WORKSHOPS, ENSURING OUR RESEARCH IS PUBLISHED IN OPEN ACCESS PUBLICATIONS, AND DATA SHARING POLICIES ENCOURAGING RESEARCH COLLABORATION ACROSS ORGANIZATIONAL BOUNDARIES. CVB PROGRAM ACTIVITIES, WITH TEAM SCIENCE AND COLLABORATION AS A CORE BELIEF, PROVIDES DIRECT PUBLIC BENEFIT THROUGH ITS RESEARCH AND EDUCATIONAL ACTIVITIES. CVB SPEARHEADS RESEARCH WITH MULTI-SECTOR PARTNERS INCLUDING ACADEMIA, GOVERNMENT, FOUNDATION RESEARCH, AND INDUSTRY ORGANIZATIONS TO ADVANCE COLLECTIVE UNDERSTANDING OF AND APPROACHES TO IMPROVING BRAIN HEALTH. FOR EXAMPLE, CVB SPONSORED THE BRAIN TRAUMA BLUEPRINT IN PARTNERSHIP WITH THE VETERANS ADMINSTRATION, NATIONAL INSTITUTES OF HEALTH AND DEPARTMENT OF DEFENSE TO ESTABLISH A RESEARCH ROADMAP FOR THE ADVANCEMENT OF PRECISION THERAPEUTIC SOLUTIONS FOR TRAUMATIC BRAIN INJURY (HTTPS://WWW.BRAINTRAUMABLUEPRINT.ORG/). CVB ALSO BROADLY DISSEMINATES RESEARCH AND EDUCATIONAL INFORMATION ABOUT PTSD, TRAUMATIC BRAIN INJURY (TBI) AND SUICIDE DIRECTLY TO THE PUBLIC THROUGH ITS WEBSITE AND SOCIAL MEDIA. THE INFORMATION IS PROVIDED IN AN ACCESSIBLE AND UNDERSTANDABLE FORMAT FOR ANY NON-MEDICAL READER, HELPING VETERANS AND OTHERS SUFFERING FROM PTSD OR TBI TO UNDERSTAND THEIR CONDITIONS AND THE SYMPTOMS AND CAUSES ASSOCIATED WITH THEM. THESE MATERIALS ALSO SERVE TO EDUCATE THE PUBLIC ABOUT PTSD AND TBI AND THE EFFECTS OF THESE CONDITIONS ON OUR VETERANS AND FAMILIES. THESE EVENTS, PROCEEDINGS, AND OTHER EDUCATIONAL OUTREACH SERVE TO ADVANCE BRAIN SCIENCE IN THE PUBLIC INTEREST. SEE WWW.COHENVETERANSBIOSCIENCE.ORG AND THE FORM 990 PROGRAM DESCRIPTIONS FOR MORE DETAILS ON THE EXPANSIVE NATURE OF THESE PROGRAMS. CVB ALSO ENLISTS THE ACTIVE SUPPORT AND PARTICIPATION OF EXPERTS, PUBLIC OFFICIALS, AND COMMUNITY LEADERS. CVB'S VETERANS ADVISORY COUNCIL ("VAC") INCLUDES SENIOR LEADERS WHO SERVED IN MILITARY LEADERSHIP ROLES AND/OR HAVE VETERAN FAMILY MEMBERS AND HAVE A DEEP PERSONAL COMMITMENT TO VETERANS' CONCERNS RELATED TO BRAIN HEALTH. VAC HELPS REPRESENT, ADVOCATE AND SUPPORT MILITARY AND VETERANS' INTERESTS TO CVB TO AID CVB IN DELIVERING MEANINGFUL RESULTS FOR VETERANS THROUGH DATA-DRIVEN SCIENCE AND ADVOCACY. MORE INFORMATION ABOUT VAC IS AVAILABLE HERE: HTTPS://WWW.COHENVETERANSBIOSCIENCE.ORG/VETERANS-ADVISORY-COUNCIL/ IN 2020, CVB EXPANDED ITS GLOBAL FOOTPRINT BY FORGING A PARTNERSHIP WITH THE EUROPEAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY TO ESTABLISH THE GLOBAL PRECLINICAL DATA FORUM, IN SUPPORT OF REPRODUCIBLE RESEARCH EFFORTS (HTTPS://WWW.PRECLINICALDATAFORUM.ORG/). CVB ALSO JOINED THE EUROPEAN FEDERATION OF PHARMACEUTICAL INDUSTRIES AND ASSOCIATIONS TO CO-SPONSOR RESEARCH WITH THE INNOVATIVE MEDICINES INITIATIVE (HTTPS://WWW.IMI.EUROPA.EU/PROJECTS-RESULTS/PROJECT-FACTSHEETS/PRISM-2) AT AN INTERNATIONAL LEVEL. IN 2022, WE HAVE EXPANDED THESE INTERNATIONAL PARTNERSHIPS THROUGH THE ESTABLISHMENT OF OUR BRAIN HEALTH NEXUS PROGRAM THAT ENGAGES LEADERS FROM THE WORLD HEALTH ORGANIZATION, OECD, EUROPEAN BRAIN COUNCIL, CANADIAN AND UK ORGANIZATIONS.FINALLY, CVB HAS A REPRESENTATIVE GOVERNING BODY THROUGH ITS UNCOMPENSATED BOARD OF DIRECTORS CONSISTING OF FIVE MEMBERS WITH EQUAL VOTING RIGHTS. FOUR OF THE FIVE MEMBERS ARE INDEPENDENT OF THE LARGEST DONOR. ALL OF THE BOARD MEMBERS ARE INDIVIDUALS WITH SPECIAL KNOWLEDGE AND EXPERTISE RELEVANT TO THE ORGANIZATION'S CHARITABLE ACTIVITIES IN BRAIN SCIENCE AND HEALTH, AS WELL AS MEMBERS WITH LONGSTANDING DEDICATION TO THE NEEDS OF VETERANS AND OTHERS WHO SUFFER FROM BRAIN DISEASES THROUGH BOTH PAID AND UNPAID WORK WITH GOVERNMENT AND OTHER NONPROFIT AGENCIES. THE QUALIFICATIONS OF THE BOARD MEMBERS INCLUDE:	FactsAndCircumstancesTestTxt

Form990 Schedule A Part VI Form990ScheduleAPartVIGrp (2 entries)

Form And Line ReferenceFormAndLineReferenceDesc

ExplanationExplanationTxt

SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME:

HRA FORFEITURES - 2020 AMOUNT: $ 28,475. 2021 AMOUNT: $ 0. STIMULUS/COVID CREDITS - 2020 AMOUNT: $ 3,629. 2021 AMOUNT: $ 2,480. OTHER REFUNDS - 2021 AMOUNT: $ 110,255.

PART II SECT C LINE 17A FACTS & CIRCUMSTANCES TEST (CONT):

BOARD CHAIR AND CEO, MAGALI HAAS, MD, PHD FOUNDED ORION BIONETWORKS (RENAMED TO COHEN VETERANS BIOSCIENCE IN 2015) WITH SPONSORSHIP FROM JANSSEN RESEARCH & DEVELOPMENT TO UNLOCK THE POWER OF SHARED DATA AND PREDICTIVE MODELING TO HELP TRANSFORM OUR UNDERSTANDING OF BRAIN DISEASES AND ACCELERATE THE SEARCH FOR CURES. DR. HAAS HAS OVER 20 YEARS OF PHARMACEUTICAL EXECUTIVE AND CLINICAL RESEARCH EXPERIENCE INCLUDING DEVELOPMENT LEADERSHIP ROLES IN MEDICAL MARKETING, FULL CLINICAL DEVELOPMENT, EARLY DEVELOPMENT, AND TRANSLATIONAL AND BIOMARKER SCIENCES IN PSYCHIATRY AND NEUROLOGY. DURING HER TENURE AT JOHNSON & JOHNSON, SHE SUCCESSFULLY FILED NDAS IN THE US AND EUROPE FOR RISPERIDONE INDICATIONS IN AUTISM, ADOLESCENT SCHIZOPHRENIA, JUVENILE BIPOLAR DISORDER AND CONDUCT DISORDERS. SHE ALSO LED DEVELOPMENT TEAMS EVALUATING COMPOUNDS FOR DEPRESSION, NEUROPATHIC PAIN, EPILEPSY, AND MIGRAINE DISORDER. SHE SERVED 3 YEARS AS CHIEF SCIENCE AND TECHNOLOGY OFFICER FOR ONE MIND FOR RESEARCH, A NONPROFIT ORGANIZATION LAUNCHED IN MAY 2012 BY PATRICK J KENNEDY. SHE ORCHESTRATED THE LAUNCH OF ONE MIND'S SEMINAL PROGRAMS, APOLLO, AN INFORMATICS RESEARCH PORTAL AND, GEMINI, AN INTERNATIONAL TBI/PTSD RESEARCH PROGRAM. AS AN "INTRAPRENEUR" AT J&J SHE ESTABLISHED THE FIRST NEUROSCIENCE TRANSLATIONAL MEDICINE & INTEGRATIVE SOLUTIONS DEPARTMENT, AND CO-FOUNDED THE FIRST COMPANION DIAGNOSTICS CENTER OF EXCELLENCE AS WELL AS J&J'S HEALTHCARE INNOVATION TEAM. SHE SERVES ON SEVERAL ADVISORY BOARDS INCLUDING ALTO NEUROSCIENCE, KREMBIL CENTRE FOR NEUROINFORMATICS, VIRTUALBRAINCLOUD, PARTNERSHIP FOR ASSESSMENT AND ACCREDITATION OF SCIENTIFIC PRACTICE (PAASP) AND INTERUNIVERSITY MICROELECTRONICS CENTRE (IMEC) AN INTERNATIONAL RESEARCH & DEVELOPMENT AND INNOVATION HUB. DR. HAAS EARNED HER BS IN BIOENGINEERING FROM THE UNIVERSITY OF PENNSYLVANIA, AN MS IN BIOMEDICAL ENGINEERING FROM RUTGERS UNIVERSITY, NEW JERSEY, AND HER MD PHD WITH DISTINCTION IN NEUROSCIENCE FROM ALBERT EINSTEIN COLLEGE OF MEDICINE, NEW YORK. BOARD MEMBER, SECRETARY, THERESA FRANGIOSA HAS EXTENSIVE EXECUTIVE EXPERIENCED BASED ON HER 25 YEAR CAREER WITH THE PHARMACEUTICAL SECTOR. IN HER ROLES WITHIN PHARMA, SHE WAS A GLOBAL LAUNCH LEADER AS WELL AS OVERSEEING EARLY COMMERCIAL STRATEGY IN NEUROSCIENCES. SHE LED LARGE SCALE TEAMS, CROSS-FUNCTIONAL TEAMS TO DEFINE DISEASE AND THERAPEUTIC AREA STRATEGIES FOR JANSSEN AND GLAXOSMITHKLINE. SHE HAS ALSO LED INDICATION PRIORITIZATION EFFORTS AND DEVELOPMENT OF OVER 200 TARGET PRODUCT PROFILES OVER A VARIETY OF DISEASE STATES, LEVERAGING WELL-ESTABLISHED PROCESSES AND FRAMEWORKS, INCLUDING DEEPER UNDERSTANDING OF PATIENT JOURNEYS TO CREATE KEY INSIGHTS. SHE HAS APPLIED HER PROFESSIONAL CAREER EXPERIENCE AND HER PASSION FOR ADVOCACY TO HELP CREATE A CHANNEL FOR FEEDBACK FROM THOSE DIAGNOSED WITH OR AT RISK FOR ALZHEIMER'S DISEASE OR DEMENTIA, THEIR CARE PARTNERS AND INDIVIDUALS WHO ARE 'WORRIED WELL', CALLED THE A-LIST. SHE IS THE LEAD INVESTIGATOR FOR THIS RESEARCH STUDY WITH IRB OVERSIGHT. MS. FRANGIOSA OBTAINED HER BACHELOR OF ADMINISTRATION, ACCOUNTING CONCENTRATION FROM URSINUS COLLEGE (COLLEGEVILLE, PA) IN 1988 AND HER MASTERS OF BUSINESS ADMINISTRATION, PHARMACEUTICAL MARKETING FROM ST. JOSEPH'S UNIVERSITY IN 1996. BOARD MEMBER, TREASURER, MICHAEL C. SULLIVAN IS THE CHIEF OF STAFF AND HEAD OF EXTERNAL AFFAIRS OF POINT72 ASSET MANAGEMENT. MR. SULLIVAN PREVIOUSLY SERVED AS A SENIOR AIDE IN THE UNITED STATES SENATE, FOCUSING ON TELECOM, TECHNOLOGY, AND FINANCE ISSUES. MR. SULLIVAN ALSO SERVED AS A STAFF MEMBER IN THE U.S. HOUSE OF REPRESENTATIVES WORKING ON SIMILAR ISSUES. BEFORE COMING TO CAPITOL HILL, MR. SULLIVAN WAS THE HEAD OF STRATEGIC DEVELOPMENT FOR A TELECOMMUNICATIONS FOCUSED TRADE ASSOCIATION. MR. SULLIVAN IS INVOLVED WITH SEVERAL VETERANS' MENTAL HEALTH-RELATED NON-PROFIT ORGANIZATIONS. HE HELPED ESTABLISH AND SERVES ON THE BOARD AND AS TREASURER OF THE COHEN VETERANS NETWORK, WHICH OPERATES A NATIONAL NETWORK OF CLINICS TO TREAT VETERANS AND THEIR FAMILY MEMBERS AFFECTED BY POST-TRAUMATIC STRESS. MR. SULLIVAN IS AN ASSOCIATE AT THE NYU-STERN ENDLESS FRONTIER LABS, WHERE HE MENTORS START-UP COMPANIES IN ARTIFICIAL INTELLIGENCE, MACHINE LEARNING, AND RELATED FIELDS. HE IS ALSO A MEMBER OF THE EXECUTIVE COMMITTEE OF STUDENTS FIRST NEW YORK, A NONPROFIT ORGANIZATION ADVOCATING FOR EDUCATIONAL REFORM IN NEW YORK STATE. MR. SULLIVAN IS A GRADUATE OF VANDERBILT UNIVERSITY. BOARD MEMBER, DAVID BIONDI, MD HAS OVER 20 YEARS OF CLINICAL EXPERIENCE IN MEDICAL PRACTICE AND HELD MEDICAL DIRECTORSHIPS AT THE US NAVAL HOSPITAL IN OKINAWA JAPAN, THE PAIN MANAGEMENT PROGRAM & HEADACHE INSTITUTE AT MARYVIEW MEDICAL CENTER IN PORTSMOUTH VA, THE PAIN DIVISION OF THE MICHIGAN HEAD PAIN & NEUROLOGICAL INSTITUTE IN ANN ARBOR MI, AND THE INTERDISCIPLINARY HEADACHE & PAIN REHABILITATION PROGRAM AT SPAULDING REHABILITATION HOSPITAL IN BOSTON MA. HE WAS PREVIOUSLY AN ASSISTANT NEUROLOGIST AT THE MASSACHUSETTS GENERAL HOSPITAL AND AN INSTRUCTOR IN NEUROLOGY AT HARVARD MEDICAL SCHOOL. DR. BIONDI SERVED AS A TRUSTEE FOR THE UNIVERSITY OF NEW ENGLAND AND WAS CHAIR OF ITS ACADEMIC AND RESEARCH AFFAIRS COMMITTEE AND VICE-CHAIR OF ITS LONG-RANGE PLANNING COMMITTEE. HE ALSO SERVED AS A DIRECTOR AND MEDICAL ADVISOR FOR THE AFTER ACTION NETWORK, A NONPROFIT VETERAN SERVICE ORGANIZATION IN KANSAS CITY MO. HE IS A FELLOW OF THE AMERICAN ACADEMY OF NEUROLOGY. DR. BIONDI HAS OVER 15 YEARS OF EXPERIENCE IN CLINICAL RESEARCH AND DEVELOPMENT OF PHARMACEUTICALS AND MEDICAL DEVICES IN THE NEUROLOGY, PSYCHIATRY, AND PAIN THERAPEUTIC AREAS. HIS EXPERIENCES INCLUDE THE DESIGN, IMPLEMENTATION, MONITORING, AND INTERPRETATION OF PHASE 2 TO PHASE 4 CLINICAL TRIALS AND IN-HOUSE AND FIELD-BASED ACTIVITIES ASSOCIATED WITH INSIGHTS GENERATION, NEW BUSINESS OPPORTUNITIES, EMERGING HEALTH POLICY, KNOWLEDGE TRANSLATION AND IMPLEMENTATION, AND ORGANIZATIONAL EFFECTIVENESS. HE PREVIOUSLY SERVED AS EXECUTIVE DIRECTOR FOR CLINICAL PROGRAMS WITH COHEN VETERANS BIOSCIENCE. DR. BIONDI RECEIVED HIS MEDICAL DEGREE FROM THE UNIVERSITY OF NEW ENGLAND, COLLEGE OF OSTEOPATHIC MEDICINE IN BIDDEFORD ME. HE COMPLETED RESIDENCY TRAINING IN NEUROLOGY AT THE NATIONAL NAVAL MEDICAL CENTER IN BETHESDA MD AND IS BOARD-CERTIFIED IN NEUROLOGY WITH SUBSPECIALTY EXPERTISE IN HEADACHE AND PAIN MEDICINE. HE RECEIVED HIS BACHELOR OF SCIENCE - MAGNA CUM LAUDE IN PHARMACY FROM THE LONG ISLAND UNIVERSITY, SCHWARTZ COLLEGE OF PHARMACY & HEALTH SCIENCE IN BROOKLYN NY. BOARD MEMBER, DR. DAVE DEMARCO IS A SENIOR ADVISOR TO C-SUITE LEADERS IN THE LIFE SCIENCES AND HEALTHCARE INDUSTRIES. HE SERVES AS CHIEF STRATEGY OFFICER FOR MATERIAL HEALTH STRATEGIES AND WORKS WITH C-SUITE EXECUTIVES ON GROWTH STRATEGIES AND TEAM PERFORMANCE IN BOTH THE FOR-PROFIT AND NON-FOR-PROFIT INDUSTRIES. HE PREVIOUSLY SERVED AS CHAIR OF THE BOARD OF THE AMERICAN DIABETES ASSOCIATION, LED ERNST & YOUNG'S (EY'S) NORTHEAST LIFE SCIENCES PRACTICE AND WAS THE DEPUTY LEADER OF THE US HEALTHCARE PRACTICE. WITH OVER 25 YEARS OF LEADERSHIP EXPERIENCE, DAVE ADVISES, COACHES AND SHARES INSIGHTS ON STRATEGY AND TRANSFORMATION, COMMERCIAL OPERATIONS, HEALTHCARE POLICY, GOVERNANCE, PUBLIC-PRIVATE-PARTNERSHIPS, AND ENTREPRENEURIAL GROWTH. WHILE SERVING ON THE BOARD OF THE AMERICAN DIABETES ASSOCIATION, HE LED BOARD INITIATIVES INVOLVING: CEO SUCCESSION, PRINCIPAL OFFICER SUCCESSION, BOARD DEVELOPMENT, POLICY CREATION, STRATEGIC PLAN IMPLEMENTATION AND TECHNOLOGY PARTNERSHIPS. DAVE HAS HELD KEY EXECUTIVE POSITIONS, INCLUDING: GLOBAL AESTHETIC FRANCHISE LEADER, SANOFI AVENTIS; US HEALTH DEPUTY LEADER, NORTHEAST REGION LIFE SCIENCES PRACTICE LEADER AND JOHNSON & JOHNSON GLOBAL CLIENT SERVICES PARTNER, EY; RESEARCH SCIENTIST, INTERNAL VENTURE LEADER, AMOCO CHEMICAL; AND COFOUNDER, IDEA CONNECTION SYSTEMS. DAVE WORKED CLOSELY WITH THE AVENTIS NA LEADERSHIP TEAM TO DEVELOP POST-MERGER INTEGRATION GROWTH STRATEGIES AND LAUNCH KEY BLOCKBUSTER PRODUCTS AIMED AT, AND SUCCEEDING IN, DOUBLING THE SIZE OF THE BUSINESS IN FOUR YEARS. AS A SENIOR PARTNER IN EY'S GLOBAL LIFE SCIENCES TEAM, DAVE PILOTED A NEW P&L ACCOUNTABLE, GO-TO-MARKET MODEL, GROWING THE NORTHEAST PRACTICE AT 30% CAGR, RESULTING IN A $400 MILLION BUSINESS. IN HIS SERVICE TO JOHNSON & JOHNSON, HE PARTNERED WITH J&J LEADERSHIP IN DEVELOPING JANSSEN HEALTHCARE INNOVATION, CHARGED WITH CREATING FUTURE BUSINESS UNITS. DAVE LED THE TRANSFORMATION OF EY'S US HEALTH PRACTICE, RESULTING IN A $750 MILLION BUSINESS. AS A MEMBER OF THE SANOFI AVENTIS NA DERMATOLOGY LEADERSHIP TEAM, DAVE DEVELOPED THE GLOBAL AESTHETIC FRANCHISE STRATEGY AND SERVED AS THE COMMERCIAL HEAD FOR EUROPE. FOR THIS TURNAROUND PROJECT, HE CREATED A PLAN TO TRIPLE EBITDA, IMPLEMENT NEW GLOBAL PRICING POLICIES AND DOUBLE CUSTOMER ACQUISITION. DAVE RECEIVED HIS B.S. FROM GROVE CITY COLLEGE AND PH.D. IN CHEMISTRY FROM PURDUE UNIVERSITY.

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

Field	Value	IRS element (for citing)
Contributor	RESTRICTED	ContributorNum

Contributor Business Name ContributorBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor US Address ContributorUSAddress

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Total Contributions	RESTRICTED	TotalContributionsAmt

Schedule C IRS990ScheduleC

Total Grassroots Lobbying TotalGrassrootsLobbyingGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$0	FilingOrganizationsTotalAmt

Total Direct Lobbying TotalDirectLobbyingGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$90,000	FilingOrganizationsTotalAmt

Total Lobbying Expend TotalLobbyingExpendGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$90,000	FilingOrganizationsTotalAmt

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$17,230,934	FilingOrganizationsTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$17,320,934	FilingOrganizationsTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$1,000,000	FilingOrganizationsTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$250,000	FilingOrganizationsTotalAmt

Tot Lbbyng Grassroot Mns Non Tx TotLbbyngGrassrootMnsNonTxGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$0	FilingOrganizationsTotalAmt

Tot Lbby Expend Mns Lbbyng Non Tx TotLbbyExpendMnsLbbyngNonTxGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$0	FilingOrganizationsTotalAmt

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$1,000,000	CurrentYearMinus3Amt
Current Year Minus2	$1,000,000	CurrentYearMinus2Amt
Current Year Minus1	$1,000,000	CurrentYearMinus1Amt
Current Year	$1,000,000	CurrentYearAmt
Total	$4,000,000	TotalAmt

Field	Value	IRS element (for citing)
Lobbying Ceiling	$6,000,000	LobbyingCeilingAmt

Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$87,500	CurrentYearMinus3Amt
Current Year Minus2	$90,000	CurrentYearMinus2Amt
Current Year Minus1	$90,000	CurrentYearMinus1Amt
Current Year	$90,000	CurrentYearAmt
Total	$357,500	TotalAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$250,000	CurrentYearMinus3Amt
Current Year Minus2	$250,000	CurrentYearMinus2Amt
Current Year Minus1	$250,000	CurrentYearMinus1Amt
Current Year	$250,000	CurrentYearAmt
Total	$1,000,000	TotalAmt

Field	Value	IRS element (for citing)
Grassroots Ceiling	$1,500,000	GrassrootsCeilingAmt

Schedule D IRS990ScheduleD

Leasehold Improvements LeaseholdImprovementsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$134,362	OtherCostOrOtherBasisAmt
Depreciation	$49,169	DepreciationAmt
Book Value	$85,193	BookValueAmt

Equipment EquipmentGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$174,076	OtherCostOrOtherBasisAmt
Depreciation	$72,520	DepreciationAmt
Book Value	$101,556	BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$1,320,522	OtherCostOrOtherBasisAmt
Depreciation	$74,351	DepreciationAmt
Book Value	$1,246,171	BookValueAmt

Field	Value	IRS element (for citing)
Total Book Value Land Buildings	$1,432,920	TotalBookValueLandBuildingsAmt

Other Assets Org OtherAssetsOrgGrp

Field	Value	IRS element (for citing)
Desc	DEPOSITS	Desc
Book Value	$883,589	BookValueAmt

Field	Value	IRS element (for citing)
Total Book Value Other Assets	$883,589	TotalBookValueOtherAssetsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

Field	Value	IRS element (for citing)
Desc	DEFERRED RENT	Desc
Amt	$139,342	Amt

Field	Value	IRS element (for citing)
Total Liability	$139,342	TotalLiabilityAmt
Footnote Text	Yes (X)	FootnoteTextInd
Total Rev Etc Audited Fincl Stmt	$18,082,398	TotalRevEtcAuditedFinclStmtAmt
Revenue Not Reported	$0	RevenueNotReportedAmt
Revenue Subtotal	$18,082,398	RevenueSubtotalAmt
Revenue Not Reported Fincl Stmt	$0	RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990	$18,082,398	TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt	$17,523,784	TotExpnsEtcAuditedFinclStmtAmt
Expenses Not Reported	$0	ExpensesNotReportedAmt
Expenses Subtotal	$17,523,784	ExpensesSubtotalAmt
Expenses Not Rpt Fincl Stmt	$0	ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990	$17,523,784	TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART X, LINE 2:	FormAndLineReferenceDesc
Explanation	TAX POSITION: THE ORGANIZATION CURRENTLY EVALUATES ALL TAX POSITIONS, AND MAKES A DETERMINATION REGARDING THE LIKELIHOOD OF THOSE POSITIONS BEING UPHELD UNDER REVIEW. THE PRIMARY TAX POSITION MADE BY THE ORGANIZATION IS THE EXISTENCE OF UNRELATED BUSINESS INCOME TAX AND THE ORGANIZATION'S STATUS AS A TAX-EXEMPT ORGANIZATION UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. FOR THE YEAR PRESENTED, THE ORGANIZATION HAS NOT RECOGNIZED ANY TAX BENEFITS OR LOSS CONTINGENCIES FOR UNCERTAIN TAX POSITIONS BASED ON THIS EVALUATION.	ExplanationTxt

Schedule F IRS990ScheduleF

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (1)	GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp

Field	Value	IRS element (for citing)
Region	EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM	RegionTxt
Offices	0	OfficesCnt
Employee	0	EmployeeCnt
Type Of Activities Conducted	GRANTS TO RECIPIENTS LOCATED IN REGION	TypeOfActivitiesConductedTxt
Specific Services Provided	N/A	SpecificServicesProvidedTxt
Region Total Expenditures	$265,464	RegionTotalExpendituresAmt

Field	Value	IRS element (for citing)
Subtotal Offices	0	SubtotalOfficesCnt
Subtotal Employees	0	SubtotalEmployeesCnt
Continuation Total Office	0	ContinuationTotalOfficeCnt
Continuation Total Employee	0	ContinuationTotalEmployeeCnt
Total Office	0	TotalOfficeCnt
Total Employee	0	TotalEmployeeCnt
Subtotal Spent	$265,464	SubtotalSpentAmt
Continuation Spent	$0	ContinuationSpentAmt
Total Spent	$265,464	TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (4 entries)

RegionRegionTxt	Purpose Of GrantPurposeOfGrantTxt	Cash GrantCashGrantAmt	Manner Of Cash DisbursementMannerOfCashDisbursementTxt	Non Cash AssistanceNonCashAssistanceAmt	Description Of Non Cash AsstDescriptionOfNonCashAsstTxt	Valuation Method UsedValuationMethodUsedDesc
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM	PLATFORM FOR THE EXCHANGE OF EXPERIMENTAL RESEARCH STANDARDS (PEERS)	$64,688	WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM	PLATFORM FOR THE EXCHANGE OF EXPERIMENTAL RESEARCH STANDARDS (PEERS)	$105,000	WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM	PLATFORM FOR THE EXCHANGE OF EXPERIMENTAL RESEARCH STANDARDS (PEERS)	$55,776	WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND & GREENLAND)	PLATFORM FOR THE EXCHANGE OF EXPERIMENTAL RESEARCH STANDARDS (PEERS)	$40,000	WIRE TRANSFER	$0	N/A	N/A

Field	Value	IRS element (for citing)
Total501c3 Org	1	Total501c3OrgCnt
Total Other Org	3	TotalOtherOrgCnt
Transfer To Foreign Corp	0	TransferToForeignCorpInd
Interest In Foreign Trust	0	InterestInForeignTrustInd
Foreign Corp Ownership	0	ForeignCorpOwnershipInd
Passive Foreign Investmest Co	0	PassiveForeignInvestmestCoInd
Foreign Partnership	0	ForeignPartnershipInd
Boycott Countries	0	BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
PART I, LINE 2:	THE ORGANIZATION REQUIRES GRANTEES TO REGULARLY PROVIDE QUALITATIVE AND QUANTITATIVE REPORTS DESCRIBING HOW FUNDS ARE BEING SPENT AND THE RESULTS THE GRANTEE HAS ACHIEVED. PROGRESS IS MEASURED AGAINST ORIGINAL AND REVISED GRANT PROPOSALS. CONTINUATION OF FUNDING IS DEPENDENT ON RESULTS AND ACCURATE, TIMELY REPORTING.
PART III ACCOUNTING METHOD:

Schedule G IRS990ScheduleG

Field	Value	IRS element (for citing)
Email Solicitations	Yes (X)	EmailSolicitationsInd
Solicitation Of Non Govt Grants	Yes (X)	SolicitationOfNonGovtGrantsInd
Solicitation Of Govt Grants	Yes (X)	SolicitationOfGovtGrantsInd
Agrmt Prof Fundraising Acty	Yes (1)	AgrmtProfFundraisingActyInd

Fundraiser Activity Info FundraiserActivityInfoGrp

Organization Business Name OrganizationBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	360 PHILANTHROPY GROUP	BusinessNameLine1Txt

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	1405 CLINTON STREET APT 204	AddressLine1Txt
City	HOBOKEN	CityNm
State Abbreviation	NJ	StateAbbreviationCd
ZIP	07030	ZIPCd

Field	Value	IRS element (for citing)
Activity	FUNDRAISING CONSULTING	ActivityTxt
Fundraiser Control Of Funds	0	FundraiserControlOfFundsInd
Gross Receipts	$0	GrossReceiptsAmt
Retained By Contractor	$36,000	RetainedByContractorAmt
Net To Organization	$0	NetToOrganizationAmt

Field	Value	IRS element (for citing)
Total Retained By Contractors	$36,000	TotalRetainedByContractorsAmt
Licensed States	MA	LicensedStatesCd
Licensed States	NY	LicensedStatesCd
Licensed States	AL	LicensedStatesCd
Licensed States	AK	LicensedStatesCd
Licensed States	AR	LicensedStatesCd
Licensed States	CA	LicensedStatesCd
Licensed States	CO	LicensedStatesCd
Licensed States	CT	LicensedStatesCd
Licensed States	DC	LicensedStatesCd
Licensed States	FL	LicensedStatesCd
Licensed States	GA	LicensedStatesCd
Licensed States	HI	LicensedStatesCd
Licensed States	IL	LicensedStatesCd
Licensed States	KS	LicensedStatesCd
Licensed States	KY	LicensedStatesCd
Licensed States	ME	LicensedStatesCd
Licensed States	MD	LicensedStatesCd
Licensed States	MI	LicensedStatesCd
Licensed States	MN	LicensedStatesCd
Licensed States	MS	LicensedStatesCd
Licensed States	NH	LicensedStatesCd
Licensed States	NV	LicensedStatesCd
Licensed States	NJ	LicensedStatesCd
Licensed States	NC	LicensedStatesCd
Licensed States	NM	LicensedStatesCd
Licensed States	ND	LicensedStatesCd
Licensed States	OH	LicensedStatesCd
Licensed States	OK	LicensedStatesCd
Licensed States	OR	LicensedStatesCd
Licensed States	PA	LicensedStatesCd
Licensed States	RI	LicensedStatesCd
Licensed States	SC	LicensedStatesCd
Licensed States	TN	LicensedStatesCd
Licensed States	UT	LicensedStatesCd
Licensed States	VA	LicensedStatesCd
Licensed States	WA	LicensedStatesCd
Licensed States	WV	LicensedStatesCd
Licensed States	WI	LicensedStatesCd

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (1)	GrantRecordsMaintainedInd

Recipient Table RecipientTable (3 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	Recipient EINRecipientEIN	IRC SectionIRCSectionDesc	Cash GrantCashGrantAmt	Non Cash AssistanceNonCashAssistanceAmt	Valuation Method UsedValuationMethodUsedDesc	Non Cash AssistanceNonCashAssistanceDesc	Purpose Of GrantPurposeOfGrantTxt
TEXAS A & M
600 TAMU COLLEGE STATION	COLLEGE STATION	TX	77843	746000531	501(C)3	$100,000	$0	N/A	N/A	ESTABLISHING CHRONIC RECORDING AND ADAPT SPS FC AND ER PROCEDURES
CHILDREN'S HOSPITAL OF PHILADELPHIA
LOCKBOX 1457 PO BOX 8500	PHILADEPHIA	PA	19178	231352166	501(C)3	$20,000	$0	N/A	N/A	MODEL OF INDIVIDUAL DIFF IN RESPONSE SOCIAL DEFEAT IN RATS
LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER NEW ORLEANS
433 BOLIVAR STREET	NEW ORLEANS	LA	70112	726087770	501(C)3	$115,883	$0	N/A	N/A	PTSD-AUD COMORBIDITY MODEL DEVELOPMENT

Field	Value	IRS element (for citing)
Total501c3 Org	3	Total501c3OrgCnt
Total Other Org	0	TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I, LINE 2:	FormAndLineReferenceDesc
Explanation	THE ORGANIZATION REQUIRES GRANTEES TO REGULARLY PROVIDE QUALITATIVE AND QUANTITATIVE REPORTS DESCRIBING HOW FUNDS ARE BEING SPENT AND THE RESULTS THE GRANTEE HAS ACHIEVED. PROGRESS IS MEASURED AGAINST ORIGINAL AND REVISED GRANT PROPOSALS. CONTINUATION OF FUNDING IS DEPENDENT ON RESULTS AND ACCURATE, TIMELY REPORTING.	ExplanationTxt

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
Form990 Of Other Organizations	Yes (X)	Form990OfOtherOrganizationsInd
Compensation Survey	Yes (X)	CompensationSurveyInd
Board Or Committee Approval	Yes (X)	BoardOrCommitteeApprovalInd
Severance Payment	0	SeverancePaymentInd
Supplemental Nonqual Rtr Plan	0	SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm	0	EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org	0	CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs	0	CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org	0	CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs	0	CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments	0	AnyNonFixedPaymentsInd
Initial Contract Exception	0	InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (11 entries)

TitleTitleTxt	Base Compensation Filing OrgBaseCompensationFilingOrgAmt	Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt	Bonus Filing OrganizationBonusFilingOrganizationAmount	Bonus Related OrganizationsBonusRelatedOrganizationsAmt	Other Compensation Filing OrgOtherCompensationFilingOrgAmt	Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt	Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt	Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt	Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt	Total Compensation Filing OrgTotalCompensationFilingOrgAmt	Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt	Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
MAGALI HAAS MD PHD
CEO & PRESIDENT	$479,600	$0	$151,207	$0	$0	$0	$25,999	$0	$0	$0	$656,806	$0	$0	$0
ALLYSON GAGE PHD
CHIEF MEDICAL OFFICER	$378,411	$0	$114,291	$0	$0	$0	$26,000	$0	$12,412	$0	$531,114	$0	$0	$0
ANDREAS JEROMIN PHD
CHIEF SCIENTIFIC OFFICER	$360,696	$0	$73,045	$0	$0	$0	$5,800	$0	$25,276	$0	$464,817	$0	$0	$0
LEE LANCASHIRE
CHIEF INFORMATION OFFICER	$218,125	$0	$122,282	$0	$0	$0	$13,625	$0	$82,216	$0	$436,248	$0	$0	$0
EVGENY RAKHMATULIN
CHIEF TECHNOLOGY OFFICER	$235,855	$0	$87,500	$0	$0	$0	$20,198	$0	$35,737	$0	$379,290	$0	$0	$0
AMANDA NICOLE HARMON
CHIEF OPERATIONS OFFICER	$256,069	$0	$26,420	$0	$0	$0	$12,999	$0	$35,737	$0	$331,225	$0	$0	$0
KERSTEN SMALL
DEPUTY DIRECTOR, TRANSLATIONAL RND	$240,970	$0	$20,000	$0	$0	$0	$16,200	$0	$35,737	$0	$312,907	$0	$0	$0
RENEE DAVIS
EXECUTIVE DIRECTOR, DEVELOPMENT	$256,286	$0	$26,000	$0	$0	$0	$17,160	$0	$12,412	$0	$311,858	$0	$0	$0
MARYAN ZIRKLE
EXECUTIVE DIRECTOR, BRAINCOMMONS	$233,619	$0	$47,196	$0	$0	$0	$16,984	$0	$12,412	$0	$310,211	$0	$0	$0
LAUREN GOLDSMITH
SENIOR DIRECTOR, CONTRACTS	$216,861	$0	$1,000	$0	$0	$0	$13,177	$0	$12,412	$0	$243,450	$0	$0	$0
MARK ZERVAS
DEPUTY DIRECTOR, TRANSLATIONAL SCIEN	$162,460	$0	$15,200	$0	$0	$0	$10,997	$0	$32,681	$0	$221,338	$0	$0	$0

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (7 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
AMENDED RETURN EXPLANATION:	RETURN AMENDED TO INCLUDE ALL STATES RECENTLY REGISTERED WITH AND FILING FORM 990 IN.
FORM 990, PART VI, SECTION B, LINE 11B	THE BOARD OF DIRECTORS REVIEWED AND APPROVED THE FORM 990 PRIOR TO ITS FILING. THE FORM 990 WAS THEN AUTHORIZED AND SIGNED BY THE ORGANIZATION'S CEO & PRESIDENT.
FORM 990, PART VI, SECTION B, LINE 12C	THE BOARD OF DIRECTORS REQUIRES AN ANNUAL DECLARATION FROM ALL BOARD MEMBERS AND SENIOR MANAGEMENT AS TO THE EXISTENCE AND DISCLOSURE OF ANY POTENTIAL CONFLICTS OF INTEREST. THE BOARD MEMBERS SIGN A DISCLOSURE STATEMENT. ANY POTENTIAL CONFLICTS ARE DISCUSSED BY THE DIS-INTERESTED BOARD MEMBERS, WHILE THE PARTY IN POTENTIAL CONFLICT IS REQUIRED TO LEAVE THE ROOM. BOARD MEETING MINUTES WILL DOCUMENT THE DISCUSSION AND DECISION MAKING PROCESS. IN THE EVENT OF A POTENTIAL CONFLICT, PROCEDURES TO OBTAIN COMPETITIVE BIDS AND DILIGENCE ON FAIR MARKET VALUE WILL BE ESTABLISHED.
FORM 990, PART VI, SECTION B, LINE 15	CVB'S EXECUTIVE COMPENSATION PROGRAM IS ADMINISTERED BY THE BOARD OF DIRECTORS. THE BOARD IS RESPONSIBLE FOR ESTABLISHING AND MAINTAINING A COMPETITIVE COMPENSATION PROGRAM FOR THE KEY EXECUTIVES OF THE ORGANIZATION. THE BOARD MEETS AS NEEDED TO REVIEW THE COMPENSATION PROGRAM AND MAKE RECOMMENDATIONS FOR ANY CHANGES, AS APPROPRIATE. A PERFORMANCE EVALUATION IS CONDUCTED AND REVIEWED EACH YEAR AND IS INTENDED TO ENSURE THAT THE COMPENSATION PROGRAM FALLS WITHIN A REASONABLE RANGE OF COMPETITIVE PRACTICES FOR COMPARABLE POSITIONS AMONG SIMILARLY SITUATED ORGANIZATIONS. FOLLOWING THIS REVIEW, THE BOARD REVIEWS AND APPROVES, FOR SELECTED KEY EXECUTIVES, BASE SALARIES AND ANNUAL INCENTIVE OPPORTUNITY ADJUSTMENTS, AND OBJECTIVES AND GOALS UPCOMING YEAR'S ANNUAL INCENTIVE PLAN. THE BOARD REVIEWS AND RECOMMENDS TO THE BOARD SALARY APPROVAL AND INCENTIVE AWARDS FOR THE CEO/PRESIDENT AND SELECTED KEY SENIOR STAFF.
FORM 990, PART VI, SECTION C, LINE 19	UPON REQUEST AND FORMS AVAILABLE THROUGH CHARITY NAVIGATOR WEBSITE AS WELL.
FORM 990, PART IX, LINE 11G	OTHER PROFESSIONAL FEES: PROGRAM SERVICE EXPENSES 195,205. MANAGEMENT AND GENERAL EXPENSES 204,798. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 400,003. RESEARCH COLLABORATION EXPENSES: PROGRAM SERVICE EXPENSES 2,431,734. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 2,431,734. CONTRACTED SERVICES: PROGRAM SERVICE EXPENSES 3,831,064. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 19,124. TOTAL EXPENSES 3,850,188.
FORM 990, PART XI, LINE 9:	CHANGE IN FUTURE GRANT OBLIGATIONS 202,850.

Schedule R IRS990ScheduleR

Id Disregarded Entities IdDisregardedEntitiesGrp (2 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	Primary ActivitiesPrimaryActivitiesTxt	Legal Domicile StateLegalDomicileStateCd	Total IncomeTotalIncomeAmt	End Of Year AssetsEndOfYearAssetsAmt	Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt
EARLY SIGNAL LLC
251 LITTLE FALLS DRIVE	WILMINGTON	DE	19808	TO HOLD INTELLECTUAL PROPERTY	DE	$0	$0	COHEN VETERANS BIOSCIENCE INC
BRAINCOMMONS LLC
251 LITTLE FALLS DRIVE	WILMINGTON	DE	19808	TO HOLD INTELLECTUAL PROPERTY	DE	$0	$0	COHEN VETERANS BIOSCIENCE INC